| Year |
Citation |
Score |
| 2021 |
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. The American Journal of Psychiatry. appiajp202020081251. PMID 33726522 DOI: 10.1176/appi.ajp.2020.20081251 |
0.3 |
|
| 2021 |
Dold M, Bartova L, Fugger G, Kautzky A, Mitschek MMM, Fabbri C, Montgomery S, Zohar J, Souery D, Mendlewicz J, Serretti A, Kasper S. Melancholic features in major depression - A European multicenter study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110285. PMID 33609603 DOI: 10.1016/j.pnpbp.2021.110285 |
0.313 |
|
| 2020 |
Dodd S, Bauer M, Carvalho AF, Eyre H, Fava M, Kasper S, Kennedy SH, Khoo JP, Lopez Jaramillo C, Malhi GS, McIntyre RS, Mitchell PB, Castro AMP, Ratheesh A, Severus E, et al. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-20. PMID 33289425 DOI: 10.1080/15622975.2020.1851052 |
0.31 |
|
| 2020 |
Dold M, Bartova L, Fugger G, Mitschek MMM, Kautzky A, Frey R, Montgomery S, Zohar J, Mendlewicz J, Souery D, Fabbri C, Serretti A, Kasper S. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 33046351 DOI: 10.1016/j.euroneuro.2020.09.636 |
0.308 |
|
| 2020 |
Fugger G, Dold M, Bartova L, Mitschek MMM, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Fabbri C, Frey R, Kasper S. Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression. The International Journal of Neuropsychopharmacology. PMID 32885810 DOI: 10.1093/ijnp/pyaa035 |
0.407 |
|
| 2020 |
Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM. Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients with Major Depressive Disorder Who Have Active Suicide Ideation with Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). The International Journal of Neuropsychopharmacology. PMID 32861217 DOI: 10.1093/ijnp/pyaa068 |
0.408 |
|
| 2020 |
Fabbri C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Riva MA, Lewis CM, Serretti A. Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110050. PMID 32738352 DOI: 10.1016/j.pnpbp.2020.110050 |
0.329 |
|
| 2020 |
Silberbauer LR, Bartova L, Papageorgiou K, Lanzenberger R, Kasper S, Winkler D. Oral Ketamine as a Treatment Option in Patients With Treatment Resistant Depression and Comorbid Arterial Hypertension. Journal of Clinical Psychopharmacology. 40: 418-420. PMID 32639297 DOI: 10.1097/JCP.0000000000001238 |
0.351 |
|
| 2020 |
Baldinger-Melich P, Gryglewski G, Philippe C, Murgaš M, James GM, Vraka C, Silberbauer L, Balber T, Vanicek T, Pichler V, Unterholzner J, Kranz GS, Hahn A, Winkler D, Mitterhauser M, ... ... Kasper S, et al. Corrigendum to "The effect of electroconvulsive therapy on cerebral monoamine oxidase a expression in treatment-resistant depression investigated using positron emission tomography" [Brain Stimul 12 (3) (2019) 714-723]. Brain Stimulation. 13: 1280-1281. PMID 32585622 DOI: 10.1016/j.brs.2020.06.009 |
0.325 |
|
| 2020 |
Dold M, Bartova L, Kasper S. Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment. The International Journal of Neuropsychopharmacology. PMID 32570275 DOI: 10.1093/ijnp/pyaa034 |
0.408 |
|
| 2020 |
Wajs E, Aluisio L, Holder R, Daly EJ, Lane R, Lim P, George JE, Morrison RL, Sanacora G, Young AH, Kasper S, Sulaiman AH, Li CT, Paik JW, Manji H, et al. Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2). The Journal of Clinical Psychiatry. 81. PMID 32316080 DOI: 10.4088/JCP.19m12891 |
0.353 |
|
| 2020 |
McAllister-Williams RH, Arango C, Blier P, Demyttenaere K, Falkai P, Gorwood P, Hopwood M, Javed A, Kasper S, Malhi GS, Soares JC, Vieta E, Young AH, Papadopoulos A, Rush AJ. The identification, assessment and management of difficult-to-treat depression: An international consensus statement. Journal of Affective Disorders. 267: 264-282. PMID 32217227 DOI: 10.1016/J.Jad.2020.02.023 |
0.342 |
|
| 2020 |
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte HH, ... ... Kasper S, et al. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D receptor agonist radioligand study. Translational Psychiatry. 10: 2. PMID 32066718 DOI: 10.1038/S41398-019-0681-5 |
0.583 |
|
| 2020 |
Fabbri C, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Uher R, Lewis CM, Serretti A. A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping. Translational Psychiatry. 10: 50. PMID 32066715 DOI: 10.1038/s41398-020-0738-5 |
0.349 |
|
| 2020 |
Fagiolini A, Albert U, Ferrando L, Herman E, Muntean C, Pálová E, Cattaneo A, Comandini A, Giorgio DD, Di Loreto G, Olivieri L, Salvatori E, Tongiani S, Kasper S. A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder. International Clinical Psychopharmacology. PMID 31972628 DOI: 10.1097/YIC.0000000000000304 |
0.393 |
|
| 2020 |
Vanicek T, Grygleweski G, Seiger R, Kautzky A, Manfred K, Mathis G, Jakob U, Lukas R, Paul M, Kasper S, Lanzenberger R. P.312 Twelve weeks of antidepressant treatment did not alter brain structure in depressive patients –A 3T-MR investigation European Neuropsychopharmacology. 31. DOI: 10.1016/J.Euroneuro.2019.12.075 |
0.371 |
|
| 2019 |
Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Tohen M, Kasper S, Moeller HJ. The CINP guidelines on the definition and the evidence-based interventions for treatment-resistant Bipolar disorder. The International Journal of Neuropsychopharmacology. PMID 31802122 DOI: 10.1093/Ijnp/Pyz064 |
0.316 |
|
| 2019 |
Gryglewski G, Seiger R, Baldinger-Melich P, Unterholzner J, Spurny B, Vanicek T, Hahn A, Kasper S, Frey R, Lanzenberger R. Changes in white matter microstructure after electroconvulsive therapy for treatment resistant depression. The International Journal of Neuropsychopharmacology. PMID 31740958 DOI: 10.1093/ijnp/pyz059 |
0.342 |
|
| 2019 |
Pjrek E, Friedrich ME, Cambioli L, Dold M, Jäger F, Komorowski A, Lanzenberger R, Kasper S, Winkler D. The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials. Psychotherapy and Psychosomatics. 1-8. PMID 31574513 DOI: 10.1159/000502891 |
0.322 |
|
| 2019 |
Vanicek T, Kranz GS, Vyssoki B, Komorowski A, Fugger G, Höflich A, Micskei Z, Milovic S, Lanzenberger R, Eckert A, Kasper S, Frey R. Repetitive Enhancement of Serum BDNF Subsequent to Continuation ECT. Acta Psychiatrica Scandinavica. PMID 31369144 DOI: 10.1111/acps.13080 |
0.328 |
|
| 2019 |
Mörkl S, Seltenreich D, Letmaier M, Bengesser S, Wurm W, Grohmann R, Bleich S, Toto S, Stübner S, Butler MI, Kasper S. Extrapyramidal reactions following treatment with antidepressants: Results of the AMSP multinational drug surveillance programme. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-9. PMID 31347932 DOI: 10.1080/15622975.2019.1648871 |
0.329 |
|
| 2019 |
Bartova L, Dold M, Kautzky A, Fabbri C, Spies M, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Schosser A, Kasper S. Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-22. PMID 31340696 DOI: 10.1080/15622975.2019.1635270 |
0.386 |
|
| 2019 |
Corponi F, Fabbri C, Bitter I, Montgomery S, Vieta E, Kasper S, Pallanti S, Serretti A. Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31255396 DOI: 10.1016/J.Euroneuro.2019.06.008 |
0.399 |
|
| 2019 |
Kraus C, Seiger R, Pfabigan D, Sladky R, Tik M, Paul K, Woletz M, Gryglewski G, Vanicek T, Komorowski A, Kasper S, Lamm C, Windischberger C, Lanzenberger R. Hippocampal Subfields in Acute and Remitted Depression - an Ultra-High Field Magnetic Resonance Imaging Study. The International Journal of Neuropsychopharmacology. PMID 31175352 DOI: 10.1093/Ijnp/Pyz030 |
0.39 |
|
| 2019 |
Gryglewski G, Klöbl M, Berroterán-Infante N, Rischka L, Balber T, Vanicek T, Pichler V, Kautzky A, Klebermass EM, Reed MB, Vraka C, Hienert M, James GM, Silberbauer L, Godbersen GM, ... ... Kasper S, et al. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31076187 DOI: 10.1016/j.euroneuro.2019.04.001 |
0.305 |
|
| 2019 |
Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S. Major depression and comorbid diabetes - Findings from the European Group for the Study of Resistant Depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109638. PMID 31054944 DOI: 10.1016/j.pnpbp.2019.109638 |
0.36 |
|
| 2019 |
Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S. Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31006562 DOI: 10.1016/j.euroneuro.2019.03.005 |
0.389 |
|
| 2019 |
Vanicek T, Kranz GS, Vyssoki B, Fugger G, Komorowski A, Höflich A, Saumer G, Milovic S, Lanzenberger R, Eckert A, Kasper S, Frey R. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression. Brain Stimulation. PMID 31000384 DOI: 10.1016/j.brs.2019.02.015 |
0.306 |
|
| 2019 |
Olgiati P, Serretti A, Souery D, Kasper S, Kraus C, Montgomery S, Zohar J, Mendlewicz J. Attrition in treatment-resistant depression: predictors and clinical impact. International Clinical Psychopharmacology. PMID 30946169 DOI: 10.1097/YIC.0000000000000261 |
0.427 |
|
| 2019 |
Kraus C, Kadriu B, Lanzenberger R, Zarate CA, Kasper S. Prognosis and improved outcomes in major depression: a review. Translational Psychiatry. 9: 127. PMID 30944309 DOI: 10.1038/s41398-019-0460-3 |
0.361 |
|
| 2019 |
Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Di Florio A, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, Hamish McAllister-Williams R, Morriss R, et al. Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: A consensus definition - CORRIGENDUM. The British Journal of Psychiatry : the Journal of Mental Science. 1. PMID 30816078 DOI: 10.1192/Bjp.2019.36 |
0.329 |
|
| 2019 |
Kasper S, Frazer A. Editorial for Treatment-Resistant Depression (TRD). The International Journal of Neuropsychopharmacology. 22: 83-84. PMID 30753655 DOI: 10.1093/Ijnp/Pyz006 |
0.354 |
|
| 2019 |
Winkler D, Reichardt B, Kranz GS, Bartova L, Kasper S, Pjrek E. Seasonality of antidepressant prescriptions and sick leaves. Journal of Psychiatric Research. 111: 128-133. PMID 30738345 DOI: 10.1016/j.jpsychires.2019.01.020 |
0.347 |
|
| 2019 |
Meyer BM, Rabl U, Huemer J, Bartova L, Kalcher K, Provenzano J, Brandner C, Sezen P, Kasper S, Schatzberg AF, Moser E, Chen G, Pezawas L. Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study. Translational Psychiatry. 9: 64. PMID 30718459 DOI: 10.1038/s41398-019-0395-8 |
0.649 |
|
| 2019 |
Kasper S. Choosing among second-generation antidepressant treatments for depressed patients with cardiac diseases. International Journal of Psychiatry in Clinical Practice. 1-15. PMID 30707042 DOI: 10.1080/13651501.2018.1519080 |
0.323 |
|
| 2019 |
Baldinger-Melich P, Gryglewski G, Philippe C, James GM, Vraka C, Silberbauer L, Balber T, Vanicek T, Pichler V, Unterholzner J, Kranz GS, Hahn A, Winkler D, Mitterhauser M, Wadsak W, ... ... Kasper S, et al. The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography. Brain Stimulation. PMID 30635228 DOI: 10.1016/j.brs.2018.12.976 |
0.399 |
|
| 2019 |
Fanelli G, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Albani D, Ferentinos P, Rujescu D, Mendlewicz J, Serretti A, Fabbri C. M74 Higher Polygenic Risk Scores For Schizophrenia May Be Suggestive Of Non-Response To Drugs For Depression In Patients With Major Depressive Disorder European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.08.174 |
0.373 |
|
| 2019 |
Klöbl M, Gryglewski G, Rischka L, Godbersen GM, Unterholzner J, Reed MB, Michenthaler P, Vanicek T, Winkler-Pjrek E, Hahn A, Kasper S, Lanzenberger R. P.3.06 Predicting antidepressant treatment response from functional connectivity European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.01.068 |
0.304 |
|
| 2019 |
Ludwig B, Carlberg L, Kienesberger K, Swoboda P, Mitschek M, Bernegger A, Inaner M, Senft B, Kapusta N, Haslacher H, Aigner M, Kasper S, Schosser A. P.1.14 Oxytocin receptor gene methylation as a molecular marker for severity of depressive symptoms in mood disorder patients European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.01.017 |
0.375 |
|
| 2019 |
Bartova L, Papageorgiou K, Milenkovic I, Dold M, Weidenauer A, Willeit M, Winkler D, Kasper S. A case report of rapid anti-suicidal and robust antidepressant effects of ketamine in post-psychotic depression European Neuropsychopharmacology. 29: S384-S385. DOI: 10.1016/j.euroneuro.2018.11.586 |
0.33 |
|
| 2019 |
Fabbri C, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Mendlewicz J, Serretti A. A genome-wide association study of treatment-resistant depression and meta-analysis with STAR*D European Neuropsychopharmacology. 29: S364-S365. DOI: 10.1016/j.euroneuro.2018.11.559 |
0.322 |
|
| 2019 |
Vanicek T, Seiger R, Gryglewski G, Kautzky A, Manfred K, Godbersen M, Rischka L, James GM, Silberbauer L, Michenthaler P, Kranz GS, Hahn A, Winkler D, Kasper S, Lanzenberger R. Segmentation of hippocampal subfields and nuclei of the amygdala with major depressive disorder and healthy controls – preliminary findings European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.472 |
0.353 |
|
| 2019 |
Kautzky A, Dold M, Bartova L, Spies M, Kranz GS, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Dikeos D, Rujescu D, Kasper S. Clinical predictors of treatment resistant depression: Replication results from the European multicenter study European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.1038 |
0.344 |
|
| 2019 |
Wajs E, Leah A, Morrison R, Daly E, Lane R, Lim P, Holder R, Sanacora G, Young AH, Kasper S, Sulaiman AH, Li CT, Paik JW, Manji H, Hough D, et al. Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.1016 |
0.331 |
|
| 2019 |
Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis C, Mendlewicz J, Serretti A. Sa105A Genome-Wide Association Study Of Treatment-Resistant Depression And Meta-Analysis Of Three Independent Samples European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.08.327 |
0.309 |
|
| 2019 |
Fabbri C, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Mendlewicz J, Lewis C, Serretti A. F105An Exome Sequencing Study In Treatment-Resistant Depression European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.08.185 |
0.326 |
|
| 2019 |
Serretti A, Fabbri C, Albani D, Kasper S, Zohar J, Souery D, Kautzky A, Montgomery S, Mendlewicz J. Whole Exome Sequencing Reveals Risk Factors In Treatment Resistant Depression European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.274 |
0.338 |
|
| 2018 |
Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Florio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, McAllister-Williams RH, Morriss R, et al. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition. The British Journal of Psychiatry : the Journal of Mental Science. 1-9. PMID 30520709 DOI: 10.1192/Bjp.2018.257 |
0.404 |
|
| 2018 |
Nussbaumer-Streit B, Pjrek E, Kien C, Gartlehner G, Bartova L, Friedrich ME, Kasper S, Winkler D. Implementing prevention of seasonal affective disorder from patients' and physicians' perspectives - a qualitative study. Bmc Psychiatry. 18: 372. PMID 30477472 DOI: 10.1186/s12888-018-1951-0 |
0.362 |
|
| 2018 |
Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis CM, Mendlewicz J, et al. Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples. The British Journal of Psychiatry : the Journal of Mental Science. 1-6. PMID 30468137 DOI: 10.1192/bjp.2018.256 |
0.35 |
|
| 2018 |
Ng CH, Kato T, Han C, Wang G, Trivedi M, Ramesh V, Shao D, Gala S, Narayanan S, Tan W, Feng Y, Kasper S. Definition of treatment-resistant depression - Asia Pacific perspectives. Journal of Affective Disorders. 245: 626-636. PMID 30445388 DOI: 10.1016/j.jad.2018.11.038 |
0.346 |
|
| 2018 |
Gryglewski G, Baldinger-Melich P, Seiger R, Godbersen GM, Michenthaler P, Klöbl M, Spurny B, Kautzky A, Vanicek T, Kasper S, Frey R, Lanzenberger R. Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis. The British Journal of Psychiatry : the Journal of Mental Science. 1-9. PMID 30442205 DOI: 10.1192/bjp.2018.224 |
0.35 |
|
| 2018 |
Mandelli L, Serretti A, Porcelli S, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J. Opinion paper: poor response to treatment of depression in people in high occupational levels. Psychological Medicine. 1-6. PMID 30311597 DOI: 10.1017/S003329171800288X |
0.376 |
|
| 2018 |
Spies M, James GM, Vraka C, Philippe C, Hienert M, Gryglewski G, Komorowski A, Kautzky A, Silberbauer L, Pichler V, Kranz GS, Nics L, Balber T, Baldinger-Melich P, Vanicek T, ... ... Kasper S, et al. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Translational Psychiatry. 8: 198. PMID 30242221 DOI: 10.1038/s41398-018-0227-2 |
0.396 |
|
| 2018 |
Höflich A, Michenthaler P, Kasper S, Lanzenberger R. Circuit mechanisms of reward, anhedonia and depression. The International Journal of Neuropsychopharmacology. PMID 30239748 DOI: 10.1093/ijnp/pyy081 |
0.357 |
|
| 2018 |
Benedetti F, Avery DH, Bauer M, Bunney WE, Çaliyurt O, Camardese G, Colombo C, Dallaspezia S, Henriksen TE, Kasper S, Kuriyama K, Lam RW, Martiny K, Meesters Y, Mishima K, et al. Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression. The American Journal of Psychiatry. 175: 905-906. PMID 30173556 DOI: 10.1176/Appi.Ajp.2018.18020231 |
0.352 |
|
| 2018 |
Fountoulakis KN, Karavelas V, Moysidou S, Mavridis D, Pastiadis K, Petalidou N, Nimatoudis I, Kasper S. Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study. Pharmacopsychiatry. PMID 30170329 DOI: 10.1055/a-0695-9223 |
0.419 |
|
| 2018 |
Bartova L, Papageorgiou K, Milenkovic I, Dold M, Weidenauer A, Willeit M, Winkler D, Kasper S. Rapid antidepressant effect of S-ketamine in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30041987 DOI: 10.1016/j.euroneuro.2018.05.007 |
0.398 |
|
| 2018 |
Dold M, Bartova L, Fugger G, Kautzky A, Souery D, Mendlewicz J, Papadimitriou GN, Dikeos D, Ferentinos P, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S. Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD). The International Journal of Neuropsychopharmacology. 21: 539-549. PMID 29860382 DOI: 10.1093/ijnp/pyy009 |
0.377 |
|
| 2018 |
Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S. Comorbid thyroid disease in patients with major depressive disorder - results from The European Group for the Study of Resistant Depression (GSRD). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29705022 DOI: 10.1016/j.euroneuro.2018.03.011 |
0.401 |
|
| 2018 |
Kraus C, Vanicek T, Weidenauer A, Khanaqa T, Stamenkovic M, Lanzenberger R, Willeit M, Kasper S. DiGeorge syndrome : Relevance of psychiatric symptoms in undiagnosed adult patients. Wiener Klinische Wochenschrift. 130: 283-287. PMID 29671046 DOI: 10.1007/s00508-018-1335-y |
0.319 |
|
| 2017 |
Olgiati P, Serretti A, Souery D, Dold M, Kasper S, Montgomery S, Zohar J, Mendlewicz J. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression. Journal of Affective Disorders. 227: 777-786. PMID 29254066 DOI: 10.1016/j.jad.2017.11.004 |
0.379 |
|
| 2017 |
Kautzky A, Dold M, Bartova L, Spies M, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Kasper S. Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample. The Journal of Clinical Psychiatry. 79. PMID 29228516 DOI: 10.4088/JCP.16m11385 |
0.313 |
|
| 2017 |
Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S. Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials. European Archives of Psychiatry and Clinical Neuroscience. PMID 29150713 DOI: 10.1007/s00406-017-0852-4 |
0.36 |
|
| 2017 |
Dold M, Bartova L, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S. Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study. Journal of Affective Disorders. 227: 254-259. PMID 29107818 DOI: 10.1016/j.jad.2017.10.033 |
0.376 |
|
| 2017 |
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Azorin JM, Yatham L, Mosolov S, Möller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-57. PMID 29098925 DOI: 10.1080/15622975.2017.1384850 |
0.324 |
|
| 2017 |
Spies M, James GM, Berroterán-Infante N, Ibeschitz H, Kranz GS, Unterholzner J, Godbersen M, Gryglewski G, Hienert M, Jungwirth J, Pichler V, Reiter B, Silberbauer L, Winkler D, Mitterhauser M, ... ... Kasper S, et al. Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography. The International Journal of Neuropsychopharmacology. PMID 29045739 DOI: 10.1093/ijnp/pyx085 |
0.323 |
|
| 2017 |
Fabbri C, Corponi F, Albani D, Raimondi I, Forloni G, Schruers K, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Cristalli CP, Mantovani V, Mendlewicz J, Serretti A. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28989100 DOI: 10.1016/j.pnpbp.2017.10.005 |
0.309 |
|
| 2017 |
Dodd S, Mitchell PB, Bauer M, Yatham L, Young AH, Kennedy SH, Williams L, Suppes T, Lopez Jaramillo C, Trivedi MH, Fava M, Rush AJ, McIntyre RS, Thase ME, Lam RW, ... ... Kasper S, et al. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-19. PMID 28984491 DOI: 10.1080/15622975.2017.1379609 |
0.399 |
|
| 2017 |
Schosser A, Carlberg L, Calati R, Serretti A, Massat I, Spindelegger C, Linotte S, Mendlewicz J, Souery D, Zohar J, Montgomery S, Kasper S. The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study. The International Journal of Neuropsychopharmacology. 20: 782-787. PMID 28977521 DOI: 10.1093/ijnp/pyx028 |
0.355 |
|
| 2017 |
Dold M, Bartova L, Rupprecht R, Kasper S. Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials. Psychotherapy and Psychosomatics. 86: 283-291. PMID 28903107 DOI: 10.1159/000477770 |
0.35 |
|
| 2017 |
Kraus C, Lanzenberger R, Kasper S. Ketamine for the Treatment of Depression. Jama Psychiatry. PMID 28700802 DOI: 10.1001/jamapsychiatry.2017.1770 |
0.38 |
|
| 2017 |
Nussbaumer-Streit B, Winkler D, Spies M, Kasper S, Pjrek E. Prevention of seasonal affective disorder in daily clinical practice: results of a survey in German-speaking countries. Bmc Psychiatry. 17: 247-247. PMID 28693583 DOI: 10.1186/S12888-017-1403-2 |
0.338 |
|
| 2017 |
Kautzky A, James GM, Philippe C, Baldinger-Melich P, Kraus C, Kranz GS, Vanicek T, Gryglewski G, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R. The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning. Translational Psychiatry. 7: e1150. PMID 28608854 DOI: 10.1038/tp.2017.108 |
0.335 |
|
| 2017 |
Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28579072 DOI: 10.1016/j.euroneuro.2017.05.004 |
0.355 |
|
| 2017 |
Bartova L, Weidenauer A, Dold M, Naderi-Heiden A, Kasper S, Willeit M, Praschak-Rieder N. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report. The Journal of Ect. PMID 28520578 DOI: 10.1097/YCT.0000000000000421 |
0.359 |
|
| 2017 |
Kasper S, Möller HJ, Volz HP, Schläfke S, Dienel A. Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set. International Clinical Psychopharmacology. PMID 28379882 DOI: 10.1097/YIC.0000000000000176 |
0.302 |
|
| 2017 |
Kraus C, Castrén E, Kasper S, Lanzenberger R. Serotonin and Neuroplasticity - Links between molecular, functional and structural pathophysiology in depression. Neuroscience and Biobehavioral Reviews. PMID 28342763 DOI: 10.1016/j.neubiorev.2017.03.007 |
0.398 |
|
| 2017 |
Dold M, Bartova L, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S. Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study. Journal of Psychiatric Research. 91: 1-13. PMID 28284107 DOI: 10.1016/j.jpsychires.2017.02.020 |
0.35 |
|
| 2017 |
Litvan Z, Bauer M, Kasper S, Frey R. Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia. International Psychogeriatrics. 1-3. PMID 28222822 DOI: 10.1017/S104161021700014X |
0.335 |
|
| 2017 |
James GM, Baldinger-Melich P, Philippe C, Kranz GS, Vanicek T, Hahn A, Gryglewski G, Hienert M, Spies M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R. Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression. Frontiers in Human Neuroscience. 11: 48. PMID 28220069 DOI: 10.3389/fnhum.2017.00048 |
0.406 |
|
| 2017 |
Kraus C, Rabl U, Vanicek T, Carlberg L, Popovic A, Spies M, Bartova L, Gryglewski G, Papageorgiou K, Lanzenberger R, Willeit M, Winkler D, Rybakowski JK, Kasper S. Administration of ketamine for unipolar and bipolar depression. International Journal of Psychiatry in Clinical Practice. 1-12. PMID 28097909 DOI: 10.1080/13651501.2016.1254802 |
0.352 |
|
| 2017 |
Kautzky A, Baldinger-Melich P, Kranz GS, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S. A New Prediction Model for Evaluating Treatment-Resistant Depression. The Journal of Clinical Psychiatry. PMID 28068461 DOI: 10.4088/JCP.15m10381 |
0.396 |
|
| 2017 |
Dold M, Aigner M, Kasper S. Augmentation of serotonin reuptake inhibitors with antipsychotic drugs in treatment-resistant obsessive-compulsive disorder: a meta-analysis European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31764-9 |
0.302 |
|
| 2017 |
Hajak G, Landowski J, Marx U, Olivier V, Picarel-Blanchot F, Bodinat CD, Kasper S. Effect of agomelatine on circadian rhythms in outpatients suffering from major depressive disorder over 6 weeks European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31526-2 |
0.376 |
|
| 2017 |
Dold M, Bartova L, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Kasper S. The relation between major depressive disorder and comorbid generalized anxiety disorder – results from a European multicenter, cross-sectional survey European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31450-5 |
0.332 |
|
| 2017 |
Bartova L, Dold M, Rupprecht R, Kasper S. A meta-analysis of dose escalation of antidepressant agents in major depressive disorder European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31446-3 |
0.351 |
|
| 2017 |
Dold M, Kautzky A, Bartova L, Rabl U, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S. Prescribing patterns of psychiatric drugs in major depressive disorder – Findings from a large European multicenter, cross-sectional study European Psychiatry. 41. DOI: 10.1016/J.Eurpsy.2017.02.371 |
0.393 |
|
| 2017 |
Bartova L, Weidenauer A, Dold M, Naderi-Heiden A, Kasper S, Willeit M, Praschak-Rieder N. Alternating intravenous racemic ketamine and electroconvulsive therapy in treatment resistant depression: A case report European Psychiatry. 41: S522-S522. DOI: 10.1016/J.EURPSY.2017.01.693 |
0.404 |
|
| 2016 |
Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines. The International Journal of Neuropsychopharmacology. PMID 27941079 DOI: 10.1093/Ijnp/Pyw109 |
0.326 |
|
| 2016 |
Dold M, Kasper S. Evidence-based pharmacotherapy of treatment-resistant unipolar depression. International Journal of Psychiatry in Clinical Practice. 1-11. PMID 27848269 DOI: 10.1080/13651501.2016.1248852 |
0.396 |
|
| 2016 |
Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence and a precise algorithm. The International Journal of Neuropsychopharmacology. PMID 27816941 DOI: 10.1093/Ijnp/Pyw100 |
0.301 |
|
| 2016 |
Dold M, Kautzky A, Bartova L, Rabl U, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S. Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27816317 DOI: 10.1016/j.euroneuro.2016.10.005 |
0.419 |
|
| 2016 |
Fountoulakis KN, Young A, Yatham L, Grunze H, Vieta E, Blier P, Moeller HJ, Kasper S. The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines. The International Journal of Neuropsychopharmacology. PMID 27815414 DOI: 10.1093/Ijnp/Pyw091 |
0.326 |
|
| 2016 |
Fountoulakis KN, Vieta E, Young A, Yatham L, Grunze H, Blier P, Moeller HJ, Kasper S. The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 4: Unmet needs in the treatment of Bipolar disorder and recommendations for future research. The International Journal of Neuropsychopharmacology. PMID 27677983 DOI: 10.1093/Ijnp/Pyw072 |
0.327 |
|
| 2016 |
Generoso MB, Trevizol AP, Kasper S, Cho HJ, Cordeiro Q, Shiozawa P. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis. International Clinical Psychopharmacology. PMID 27643884 DOI: 10.1097/YIC.0000000000000147 |
0.342 |
|
| 2016 |
Kaltenboeck A, Winkler D, Kasper S. Bipolar and related disorders in DSM-5 and ICD-10. Cns Spectrums. 1-6. PMID 27378177 DOI: 10.1017/S1092852916000079 |
0.312 |
|
| 2016 |
Mandelli L, Souery D, Bartova L, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A. Bipolar II disorder as a risk factor for postpartum depression. Journal of Affective Disorders. 204: 54-58. PMID 27327115 DOI: 10.1016/j.jad.2016.06.025 |
0.325 |
|
| 2016 |
Mandelli L, Serretti A, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J. High occupational level is associated with poor response to treatment of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27211903 DOI: 10.1016/j.euroneuro.2016.05.002 |
0.401 |
|
| 2016 |
Möller HJ, Bandelow B, Volz HP, Barnikol UB, Seifritz E, Kasper S. The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice. European Archives of Psychiatry and Clinical Neuroscience. PMID 27002521 DOI: 10.1007/s00406-016-0684-7 |
0.403 |
|
| 2016 |
Klein M, Schmoeger M, Kasper S, Schosser A. Meta-analysis of the COMT Val158Met polymorphism in major depressive disorder: the role of gender. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-12. PMID 26813412 DOI: 10.3109/15622975.2015.1083615 |
0.362 |
|
| 2016 |
Pjrek E, Baldinger-Melich P, Spies M, Papageorgiou K, Kasper S, Winkler D. Epidemiology and socioeconomic impact of seasonal affective disorder in Austria. European Psychiatry. 32: 28-33. PMID 26802981 DOI: 10.1016/J.Eurpsy.2015.11.001 |
0.326 |
|
| 2016 |
Balestri M, Calati R, Souery D, Kautzky A, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A. Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study. Journal of Affective Disorders. 189: 224-32. PMID 26451508 DOI: 10.1016/j.jad.2015.09.033 |
0.336 |
|
| 2016 |
Kautzky A, Dold M, Gryglewski G, Pia B, Spies M, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S. PS87. An update on prediction of treatment outcome in treatment resistant depression. The International Journal of Neuropsychopharmacology. 19: 30-30. DOI: 10.1093/Ijnp/Pyw043.087 |
0.319 |
|
| 2016 |
Mandelli L, Serretti A, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J. P.2.f.024 - High occupational level is associated with poor response to treatment of depression European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31466-3 |
0.338 |
|
| 2016 |
Bartova L, Dold M, Kautzky A, Rabl U, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S. Epidemiology of psychopharmacological options in unipolar major depression in European tertiary psychiatric treatment centers European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31386-4 |
0.379 |
|
| 2016 |
Rabl U, Provenzano J, Meyer B, Bartova L, Ortner N, Sezen P, Moser E, Kasper S, Pezawas L. Effects of antidepressant treatment with escitalopram on hippocampal structure and connectivity − a longitudinal study European Neuropsychopharmacology. 26: S379. DOI: 10.1016/S0924-977X(16)31327-X |
0.582 |
|
| 2016 |
Baldinger-Melich P, James GM, Hahn A, Mitterhauser M, Wadsak W, Kasper S, Frey R, Lanzenberger R. Effect of electroconvulsive therapy on interregional serotonin-1A receptor binding correlations in depressed patients European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31223-8 |
0.336 |
|
| 2015 |
Kasper S, Volz HP, Dienel A, Schläfke S. Efficacy of Silexan in mixed anxiety-depression - A randomized, placebo-controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26718792 DOI: 10.1016/j.euroneuro.2015.12.002 |
0.401 |
|
| 2015 |
Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment - a European multicentre study. International Clinical Psychopharmacology. PMID 26544898 DOI: 10.1097/YIC.0000000000000101 |
0.317 |
|
| 2015 |
Kasper S, Dold M. Factors contributing to the increasing placebo response in antidepressant trials. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 304-6. PMID 26407782 DOI: 10.1002/wps.20245 |
0.335 |
|
| 2015 |
Bartova L, Vogl SE, Stamenkovic M, Praschak-Rieder N, Naderi-Heiden A, Kasper S, Willeit M. Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26302763 DOI: 10.1016/j.euroneuro.2015.07.021 |
0.361 |
|
| 2015 |
Kasper S, Anghelescu I, Dienel A. Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep - A randomized, placebo-controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26293583 DOI: 10.1016/j.euroneuro.2015.07.024 |
0.328 |
|
| 2015 |
Spies M, Knudsen GM, Lanzenberger R, Kasper S. The serotonin transporter in psychiatric disorders: insights from PET imaging. The Lancet. Psychiatry. 2: 743-55. PMID 26249305 DOI: 10.1016/S2215-0366(15)00232-1 |
0.403 |
|
| 2015 |
Kasper S. Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials. Wiener Medizinische Wochenschrift (1946). 165: 217-28. PMID 26092515 DOI: 10.1007/s10354-015-0360-y |
0.378 |
|
| 2015 |
Zaninotto L, Souery D, Calati R, Di Nicola M, Montgomery S, Kasper S, Zohar J, Mendlewicz J, Robert Cloninger C, Serretti A, Janiri L. Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression. Journal of Affective Disorders. 184: 51-59. PMID 26070046 DOI: 10.1016/j.jad.2015.05.036 |
0.392 |
|
| 2015 |
Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25939614 DOI: 10.1093/ijnp/pyv047 |
0.336 |
|
| 2015 |
Zaninotto L, Souery D, Calati R, Camardese G, Janiri L, Montgomery S, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Serretti A. Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 13: 48-52. PMID 25912537 DOI: 10.9758/cpn.2015.13.1.48 |
0.406 |
|
| 2015 |
Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S, Kasper S, Greil W. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 763-72. PMID 25907249 DOI: 10.1016/j.euroneuro.2015.03.017 |
0.35 |
|
| 2015 |
Bartova L, Meyer BM, Diers K, Rabl U, Scharinger C, Popovic A, Pail G, Kalcher K, Boubela RN, Huemer J, Mandorfer D, Windischberger C, Sitte HH, Kasper S, Praschak-Rieder N, et al. Reduced default mode network suppression during a working memory task in remitted major depression. Journal of Psychiatric Research. 64: 9-18. PMID 25801734 DOI: 10.1016/J.Jpsychires.2015.02.025 |
0.625 |
|
| 2015 |
Dold M, Aigner M, Klabunde M, Treasure J, Kasper S. Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials. Psychotherapy and Psychosomatics. 84: 110-116. PMID 25722106 DOI: 10.1159/000369978 |
0.312 |
|
| 2015 |
Baldinger P, Höflich AS, Mitterhauser M, Hahn A, Rami-Mark C, Spies M, Wadsak W, Lanzenberger R, Kasper S. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25522403 DOI: 10.1093/ijnp/pyu063 |
0.325 |
|
| 2015 |
Kasper S, Montagnani G, Trespi G, Di Fiorino M. Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidone. International Clinical Psychopharmacology. 30: 14-22. PMID 25356632 DOI: 10.1097/YIC.0000000000000053 |
0.369 |
|
| 2015 |
Holl AK, Grohmann R, Letmaier M, Painold A, Mörkl S, Toto S, Kasper S. Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011. European Archives of Psychiatry and Clinical Neuroscience. 265: 199-208. PMID 25138236 DOI: 10.1007/s00406-014-0523-7 |
0.369 |
|
| 2015 |
Carlberg L, Schosser A, Calati R, Serretti A, Massat I, Papageorgiou K, Kocabas NA, Mendlewicz J, Zohar J, Montgomery SA, Souery D, Kasper S. Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression. The International Journal of Neuroscience. 125: 336-43. PMID 24955721 DOI: 10.3109/00207454.2014.936554 |
0.344 |
|
| 2015 |
Bartova L, Vogl SE, Stamenkovic M, Praschak-Rieder N, Naderi-Heiden A, Kasper S, Willeit M. P.1.g.062 Combined administration of oral tranylcypromine and intravenous S-ketamine in treatment-resistant depression: A case report European Neuropsychopharmacology. 25. DOI: 10.1016/S0924-977X(15)30314-X |
0.338 |
|
| 2015 |
Dold M, Aigner M, Treasure J, Kasper S. Are Second-generation Antipsychotic Drugs Effective in Treating Anorexia Nervosa? European Psychiatry. 30: 1339. DOI: 10.1016/S0924-9338(15)31044-0 |
0.307 |
|
| 2015 |
Frey R, Spies M, Fugger G, Baldinger P, Kasper S. Agitation in Schizophrenia and Mania: Consensus Statement by the Austrian Society for Neuropsychopharmacology and Biological Psychiatry (OGPB) European Psychiatry. 30: 1021. DOI: 10.1016/S0924-9338(15)30801-4 |
0.309 |
|
| 2015 |
Bartova L, Vogl S, Stamenkovic M, Kasper S, Willeit M. Intravenous Administration of S-ketamine in a Severely Depressed Treatment-resistant Patient Receiving Tranylcypromine: a Case Report European Psychiatry. 30: 351. DOI: 10.1016/S0924-9338(15)30276-5 |
0.357 |
|
| 2015 |
Kasper S. European Program for Treatment Resistant Depression European Psychiatry. 30: 59. DOI: 10.1016/S0924-9338(15)30049-3 |
0.338 |
|
| 2015 |
Kasper S. Psychopharmacotherapy in Cardiovascular Diseases European Psychiatry. 30: 46. DOI: 10.1016/S0924-9338(15)30037-7 |
0.364 |
|
| 2014 |
Souery D, Calati R, Papageorgiou K, Juven-Wetzler A, Gailledreau J, Modavi D, Sentissi O, Pitchot W, Papadimitriou GN, Dikeos D, Montgomery S, Kasper S, Zohar J, Serretti A, Mendlewicz J. What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-11. PMID 25535987 DOI: 10.3109/15622975.2014.987814 |
0.358 |
|
| 2014 |
Slyepchenko A, Carvalho AF, Cha DS, Kasper S, McIntyre RS. Gut emotions - mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders. Cns & Neurological Disorders Drug Targets. 13: 1770-86. PMID 25470391 DOI: 10.2174/1871527313666141130205242 |
0.368 |
|
| 2014 |
Kutzelnigg A, Kopeinig M, Chen CK, Fábián A, Pujol-Luna MG, Shin YC, Treuer T, D'yachkova Y, Deix C, Kasper S, Doby D. Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study. International Journal of Bipolar Disorders. 2: 13. PMID 25360398 DOI: 10.1186/s40345-014-0013-x |
0.344 |
|
| 2014 |
Meyer BM, Huemer J, Rabl U, Boubela RN, Kalcher K, Berger A, Banaschewski T, Barker G, Bokde A, Büchel C, Conrod P, Desrivières S, Flor H, Frouin V, Gallinat J, ... ... Kasper S, et al. Oppositional COMT Val158Met effects on resting state functional connectivity in adolescents and adults. Brain Structure & Function. PMID 25319752 DOI: 10.1007/S00429-014-0895-5 |
0.582 |
|
| 2014 |
Kasper S. Treatment-resistant depression: a challenge for future research. Acta Neuropsychiatrica. 26: 131-3. PMID 25279416 DOI: 10.1017/neu.2014.8 |
0.323 |
|
| 2014 |
Carlberg L, Scheibelreiter J, Hassler MR, Schloegelhofer M, Schmoeger M, Ludwig B, Kasper S, Aschauer H, Egger G, Schosser A. Brain-derived neurotrophic factor (BDNF)-epigenetic regulation in unipolar and bipolar affective disorder. Journal of Affective Disorders. 168: 399-406. PMID 25106037 DOI: 10.1016/j.jad.2014.07.022 |
0.331 |
|
| 2014 |
Kasper S, Kranz GS, Lanzenberger R. Testosterone, neural circuits, and male depression. Biological Psychiatry. 76: 272-3. PMID 25060786 DOI: 10.1016/j.biopsych.2014.06.010 |
0.315 |
|
| 2014 |
Rabl U, Meyer BM, Diers K, Bartova L, Berger A, Mandorfer D, Popovic A, Scharinger C, Huemer J, Kalcher K, Pail G, Haslacher H, Perkmann T, Windischberger C, Brocke B, ... ... Kasper S, et al. Additive gene-environment effects on hippocampal structure in healthy humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9917-26. PMID 25057194 DOI: 10.1523/Jneurosci.3113-13.2014 |
0.565 |
|
| 2014 |
Michl J, Scharinger C, Zauner M, Kasper S, Freissmuth M, Sitte HH, Ecker GF, Pezawas L. A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinities. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1463-74. PMID 25044049 DOI: 10.1016/J.Euroneuro.2014.06.013 |
0.594 |
|
| 2014 |
Winkler D, Pjrek E, Lanzenberger R, Baldinger P, Eitel D, Kasper S, Frey R. Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy. Journal of Psychiatric Research. 57: 96-100. PMID 24998016 DOI: 10.1016/j.jpsychires.2014.06.006 |
0.364 |
|
| 2014 |
Hirschfeld R, Keller M, Bourgeois M, Baldwin D, Healy D, Humble M, Kasper S, Montgomery S. Focus on social functioning in depression. International Journal of Psychiatry in Clinical Practice. 2: 241-3. PMID 24927085 DOI: 10.3109/13651509809115367 |
0.376 |
|
| 2014 |
Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R. Neurotransmitters and electroconvulsive therapy. The Journal of Ect. 30: 116-21. PMID 24820941 DOI: 10.1097/YCT.0000000000000138 |
0.361 |
|
| 2014 |
Fabbri C, Marsano A, Albani D, Chierchia A, Calati R, Drago A, Crisafulli C, Calabrò M, Kasper S, Lanzenberger R, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, et al. PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway. The Pharmacogenomics Journal. 14: 463-72. PMID 24709691 DOI: 10.1038/tpj.2014.15 |
0.332 |
|
| 2014 |
Di Fiorino M, Montagnani G, Trespi G, Kasper S. Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia: a randomized, open-label, parallel-group, flexible-dose study. International Clinical Psychopharmacology. 29: 166-76. PMID 24681810 DOI: 10.1097/YIC.0000000000000017 |
0.386 |
|
| 2014 |
Scharinger C, Rabl U, Kasess CH, Meyer BM, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, ... Kasper S, et al. Platelet serotonin transporter function predicts default-mode network activity. Plos One. 9: e92543. PMID 24667541 DOI: 10.1371/Journal.Pone.0092543 |
0.567 |
|
| 2014 |
Hahn A, Haeusler D, Kraus C, Höflich AS, Kranz GS, Baldinger P, Savli M, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R. Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression. Human Brain Mapping. 35: 3857-66. PMID 24443158 DOI: 10.1002/hbm.22442 |
0.396 |
|
| 2014 |
Kasper S, Iglesias-GarcÃa C, Schweizer E, Wilson J, DuBrava S, Prieto R, Pitman VW, Knapp L. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 685-95. PMID 24351233 DOI: 10.1017/S1461145713001557 |
0.341 |
|
| 2014 |
Kasper S, Brasser M, Schweizer E, Lyndon G, Prieto R. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 125-32. PMID 24290532 DOI: 10.1016/j.euroneuro.2013.10.015 |
0.364 |
|
| 2014 |
Serretti A, Chiesa A, Calati R, Sentissi O, Akimova E, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Amital D, Montgomery S, Souery D. Family history of major depression and residual symptoms in responder and non-responder depressed patients. Comprehensive Psychiatry. 55: 51-5. PMID 24156872 DOI: 10.1016/j.comppsych.2013.08.002 |
0.34 |
|
| 2014 |
Baldinger P, Kranz GS, Haeusler D, Savli M, Spies M, Philippe C, Hahn A, Höflich A, Wadsak W, Mitterhauser M, Lanzenberger R, Kasper S. Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET. Neuroimage. 88: 252-62. PMID 24121201 DOI: 10.1016/j.neuroimage.2013.10.002 |
0.327 |
|
| 2014 |
Baldinger P, Hahn A, Mitterhauser M, Kranz GS, Friedl M, Wadsak W, Kraus C, Ungersböck J, Hartmann A, Giegling I, Rujescu D, Kasper S, Lanzenberger R. Impact of COMT genotype on serotonin-1A receptor binding investigated with PET. Brain Structure & Function. 219: 2017-28. PMID 23928748 DOI: 10.1007/s00429-013-0621-8 |
0.333 |
|
| 2014 |
Savli M, Baldinger P, Haeusler D, Kranz GS, Philippe C, Spies M, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R. P.2.b.041 Alterations of molecular connectivity in major depression before and during treatment with selective serotonin reuptake inhibitors European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70642-X |
0.365 |
|
| 2014 |
Kautzky A, Calati R, Baldinger P, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S. P.2.b.035 The combined effect of genetic polymorphisms and clinical parameters on treatment response and resistance in major depressive disorder European Neuropsychopharmacology. 24: S399. DOI: 10.1016/S0924-977X(14)70636-4 |
0.319 |
|
| 2014 |
Balestri M, Calati R, Souery D, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A. P.3.015 Socio-demographic and clinical predictors of antidepressant remission and response in treatment resistant depression European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70075-6 |
0.367 |
|
| 2014 |
Kautzky A, Baldinger P, Calati R, Souery D, Montgomery S, Mendlewicz J, Zohar J, Serretti A, Lanzenberger R, Kasper S. P.3.013 Genetic variants in ST8SIA2 gene influence treatment outcome in treatment resistant depression: a European multicenter study European Neuropsychopharmacology. 24: S65-S66. DOI: 10.1016/S0924-977X(14)70073-2 |
0.343 |
|
| 2014 |
Kasper S. EPA-1442 - Depression: Personalised medicine or stratified medicine? European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78642-0 |
0.393 |
|
| 2013 |
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, ... ... Kasper S, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. The American Journal of Psychiatry. 170: 1249-62. PMID 24030475 DOI: 10.1176/Appi.Ajp.2013.13020185 |
0.356 |
|
| 2013 |
Kasper S, Hajak G. The efficacy of agomelatine in previously-treated depressed patients. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 814-21. PMID 23820051 DOI: 10.1016/j.euroneuro.2013.05.010 |
0.413 |
|
| 2013 |
Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder. Journal of Affective Disorders. 151: 209-19. PMID 23810357 DOI: 10.1016/j.jad.2013.05.079 |
0.388 |
|
| 2013 |
Kasper S. An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review. International Journal of Psychiatry in Clinical Practice. 17: 15-22. PMID 23808618 DOI: 10.3109/13651501.2013.813555 |
0.353 |
|
| 2013 |
Serretti A, Chiesa A, Souery D, Calati R, Sentissi O, Kasper S, Akimova E, Marsano A, Balestri M, Alberti S, Zohar J, Amital D, Montgomery S, Mendlewicz J. Social adjustment among treatment responder patients with mood disorders. Journal of Affective Disorders. 150: 961-6. PMID 23764379 DOI: 10.1016/j.jad.2013.05.021 |
0.354 |
|
| 2013 |
Bandelow B, Boerner J R, Kasper S, Linden M, Wittchen HU, Möller HJ. The diagnosis and treatment of generalized anxiety disorder. Deutsches ã„Rzteblatt International. 110: 300-9; quiz 310. PMID 23671484 DOI: 10.3238/arztebl.2013.0300 |
0.348 |
|
| 2013 |
Höflich A, Savli M, Comasco E, Moser U, Novak K, Kasper S, Lanzenberger R. Neuropsychiatric deep brain stimulation for translational neuroimaging. Neuroimage. 79: 30-41. PMID 23631986 DOI: 10.1016/j.neuroimage.2013.04.065 |
0.309 |
|
| 2013 |
Antypa N, Calati R, Souery D, Pellegrini S, Sentissi O, Amital D, Moser U, Montgomery S, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Serretti A. Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients. Journal of Affective Disorders. 150: 649-52. PMID 23537781 DOI: 10.1016/j.jad.2013.02.036 |
0.341 |
|
| 2013 |
Calati R, Crisafulli C, Balestri M, Serretti A, Spina E, Calabrò M, Sidoti A, Albani D, Massat I, Höfer P, Amital D, Juven-Wetzler A, Kasper S, Zohar J, Souery D, et al. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 44: 271-8. PMID 23537502 DOI: 10.1016/j.pnpbp.2013.03.005 |
0.336 |
|
| 2013 |
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 154-219. PMID 23480132 DOI: 10.3109/15622975.2013.770551 |
0.399 |
|
| 2013 |
Demyttenaere K, Corruble E, Hale A, Quera-Salva MA, Picarel-Blanchot F, Kasper S. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline. Cns Spectrums. 18: 163-70. PMID 23472671 DOI: 10.1017/S1092852913000060 |
0.365 |
|
| 2013 |
Serretti A, Souery D, Antypa N, Calati R, Sentissi O, Amital D, Moser U, Kasper S, Zohar J, Mendlewicz J. The impact of adverse life events on clinical features and interaction with gene variants in mood disorder patients. Psychopathology. 46: 384-9. PMID 23407025 DOI: 10.1159/000345358 |
0.342 |
|
| 2013 |
Hahn A, Nics L, Baldinger P, Wadsak W, Savli M, Kraus C, Birkfellner W, Ungersboeck J, Haeusler D, Mitterhauser M, Karanikas G, Kasper S, Frey R, Lanzenberger R. Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635. Nuclear Medicine and Biology. 40: 371-7. PMID 23375480 DOI: 10.1016/j.nucmedbio.2012.12.011 |
0.342 |
|
| 2013 |
Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R. Impact of electroconvulsive therapy on 5-HT1A receptor binding in major depression. Molecular Psychiatry. 18: 1. PMID 23250327 DOI: 10.1038/mp.2012.177 |
0.335 |
|
| 2013 |
Amital D, Fostick L, Silberman A, Calati R, Spindelegger C, Serretti A, Juven-Wetzler A, Souery D, Mendlewicz J, Montgomery S, Kasper S, Zohar J. Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 895-901. PMID 23121858 DOI: 10.1016/j.euroneuro.2012.09.002 |
0.403 |
|
| 2013 |
Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S. The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience. 263: 385-91. PMID 23081704 DOI: 10.1007/s00406-012-0375-y |
0.346 |
|
| 2013 |
Linden M, Bandelow B, Boerner RJ, Brasser M, Kasper S, Möller HJ, Pyrkosch L, Volz HP, Wittchen HU. The best next drug in the course of generalized anxiety disorders: the "PN-GAD-algorithm". International Journal of Psychiatry in Clinical Practice. 17: 78-89. PMID 22917251 DOI: 10.3109/13651501.2012.722645 |
0.303 |
|
| 2013 |
Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Molecular Psychiatry. 18: 93-100. PMID 22751491 DOI: 10.1038/mp.2012.93 |
0.357 |
|
| 2013 |
Höfer P, Lanzenberger R, Kasper S. Testosterone in the brain: neuroimaging findings and the potential role for neuropsychopharmacology. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 79-88. PMID 22578782 DOI: 10.1016/j.euroneuro.2012.04.013 |
0.344 |
|
| 2013 |
Serretti A, Chiesa A, Calati R, Linotte S, Sentissi O, Papageorgiou K, Kasper S, Zohar J, De Ronchi D, Mendlewicz J, Amital D, Montgomery S, Souery D. Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience. 263: 93-103. PMID 22569753 DOI: 10.1007/s00406-012-0322-y |
0.359 |
|
| 2013 |
Calati R, Souery D, Montgomery S, Kasper S, Zohar J, Mendlewicz J, Serretti A. P.2.f.015 A prospective study of escitalopram in treatment resistant depression not responding to venlafaxine European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70638-2 |
0.341 |
|
| 2013 |
Hahn A, Haeusler D, Kraus C, Höflich AS, Kranz GS, Baldinger P, Mitterhauser M, Wadsak W, Kasper S, Lanzenberger R. P.2.b.044 Serotonin transporter association between dorsal raphe and ventral striatum is diminished in major depression European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70543-1 |
0.343 |
|
| 2013 |
Baldinger P, Mitterhauser M, Bilban M, Kraus C, Ungersboeck J, Jeitler M, Wadsak W, Rujescu D, Kasper S, Lanzenberger R. P.1.i.013 No effect of TPH1, MAO-A, 5-HT1A and 5-HT2A gene variants on 5-HT1A binding potential in healthy subjects measured with PET European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70421-8 |
0.307 |
|
| 2013 |
Fabbri C, Gurwitz D, Stingl J, Crisafulli C, Spina E, Kasper S, Zohar J, Souery D, Mendlewicz J, Serretti A. P.1.a.016 CHL1 gene: a new promising antidepressant response marker in major depression European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70254-2 |
0.349 |
|
| 2013 |
Baldinger P, Kranz GS, Savli M, Wadsak W, Haeusler D, Hahn A, Mitterhauser M, Philippe C, Kasper S, Lanzenberger R. P.4.016 Regional differences of SERT occupancy in major depression: an in vivo PET study using [C]DASB European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70091-9 |
0.347 |
|
| 2013 |
Kasper S, Iglesias-García C, Schweizer E, Wilson J, Dubrava S, Prieto R, Pitman VW, Knapp L. 1019 – Safety of discontinuation of pregabalin after long-term treatment in subjects with generalised anxiety disorder (GAD) European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76147-9 |
0.329 |
|
| 2013 |
Kasper S, Iglesias-García C, Schweizer E, Wilson J, Dubrava S, Prieto R, Pitman VW, Knapp L. 1018 – Long-term efficacy and safety study of pregabalin in subjects with generalised anxiety disorder (GAD) European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76146-7 |
0.321 |
|
| 2013 |
Calati R, Crisafulli C, Balestri M, Serretti A, Spina E, Calabrò M, Sidoti A, Albani D, Massat I, Höfer P, Amital D, Juven-Wetzler A, Kasper S, Zohar J, Souery D, et al. Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278] Progress in Neuro-Psychopharmacology and Biological Psychiatry. 46: 70. DOI: 10.1016/j.pnpbp.2013.07.001 |
0.333 |
|
| 2013 |
Fagiolini A, Comandini A, Dell’Osso MC, Kasper S. Erratum to: Rediscovering Trazodone for the Treatment of Major Depressive Disorder Cns Drugs. 27: 677-677. DOI: 10.1007/S40263-013-0088-4 |
0.371 |
|
| 2013 |
Serretti A, Chiesa A, Ronchi DD, Linotte S, Sentissi O, Papageorgiou K, Kasper S, Zohar J, Mendlewicz J, Amital D, Montgomery S, Souery D, Calati R. Erratum: Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder(Eur Arch Psychiatry Clin Neurosci (2013) 263 (617)) European Archives of Psychiatry and Clinical Neuroscience. 263: 617. DOI: 10.1007/S00406-013-0429-9 |
0.394 |
|
| 2012 |
Fagiolini A, Comandini A, Catena Dell'Osso M, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. Cns Drugs. 26: 1033-49. PMID 23192413 DOI: 10.1007/s40263-012-0010-5 |
0.427 |
|
| 2012 |
Kalcher K, Huf W, Boubela RN, Filzmoser P, Pezawas L, Biswal B, Kasper S, Moser E, Windischberger C. Fully exploratory network independent component analysis of the 1000 functional connectomes database. Frontiers in Human Neuroscience. 6: 301. PMID 23133413 DOI: 10.3389/Fnhum.2012.00301 |
0.557 |
|
| 2012 |
Lanzenberger R, Kranz GS, Haeusler D, Akimova E, Savli M, Hahn A, Mitterhauser M, Spindelegger C, Philippe C, Fink M, Wadsak W, Karanikas G, Kasper S. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas. Neuroimage. 63: 874-81. PMID 22828162 DOI: 10.1016/j.neuroimage.2012.07.023 |
0.374 |
|
| 2012 |
Savli M, Bauer A, Mitterhauser M, Ding YS, Hahn A, Kroll T, Neumeister A, Haeusler D, Ungersboeck J, Henry S, Isfahani SA, Rattay F, Wadsak W, Kasper S, Lanzenberger R. Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage. 63: 447-59. PMID 22789740 DOI: 10.1016/J.Neuroimage.2012.07.001 |
0.322 |
|
| 2012 |
Höflich A, Baldinger P, Savli M, Lanzenberger R, Kasper S. Imaging treatment effects in depression. Reviews in the Neurosciences. 23: 227-52. PMID 22752781 DOI: 10.1515/revneuro-2012-0038 |
0.394 |
|
| 2012 |
Fountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, Versiani M, Tandon R, Möller HJ, Vieta E. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience. 262: 1-48. PMID 22622948 DOI: 10.1007/S00406-012-0323-X |
0.396 |
|
| 2012 |
Mendlewicz J, Crisafulli C, Calati R, Kocabas NA, Massat I, Linotte S, Kasper S, Fink M, Sidoti A, Scantamburlo G, Ansseau M, Antonijevic I, Forray C, Snyder L, Bollen J, et al. Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression. Neuroscience Letters. 516: 85-8. PMID 22487732 DOI: 10.1016/j.neulet.2012.03.063 |
0.304 |
|
| 2012 |
Schosser A, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Kasper S. European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 453-68. PMID 22464339 DOI: 10.1016/j.euroneuro.2012.02.006 |
0.393 |
|
| 2012 |
Schlaepfer TE, Agren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt DJ, Kasper S. The hidden third: improving outcome in treatment-resistant depression. Journal of Psychopharmacology (Oxford, England). 26: 587-602. PMID 22236505 DOI: 10.1177/0269881111431748 |
0.383 |
|
| 2012 |
Fischer R, Kasper S, Pjrek E, Winkler D. On the application of light therapy in German-speaking countries. European Archives of Psychiatry and Clinical Neuroscience. 262: 501-5. PMID 22228483 DOI: 10.1007/s00406-011-0286-3 |
0.343 |
|
| 2012 |
Serretti A, Chiesa A, Crisafulli C, Massat I, Linotte S, Calati R, Kasper S, Bailer U, Lecrubier Y, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, et al. Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression. Neuropsychobiology. 65: 70-5. PMID 22222462 DOI: 10.1159/000329553 |
0.346 |
|
| 2012 |
Möller HJ, Bitter I, Bobes J, Fountoulakis K, Höschl C, Kasper S. Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression. European Psychiatry : the Journal of the Association of European Psychiatrists. 27: 114-28. PMID 22119161 DOI: 10.1016/J.Eurpsy.2011.08.002 |
0.394 |
|
| 2012 |
Boubela RN, Huf W, Kalcher K, Sladky R, Filzmoser P, Pezawas L, Kasper S, Windischberger C, Moser E. A highly parallelized framework for computationally intensive MR data analysis. Magma (New York, N.Y.). 25: 313-20. PMID 22086306 DOI: 10.1007/S10334-011-0290-7 |
0.543 |
|
| 2012 |
Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, Möller HJ. Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. European Archives of Psychiatry and Clinical Neuroscience. 262: 13-22. PMID 22083391 DOI: 10.1007/S00406-011-0274-7 |
0.427 |
|
| 2012 |
Kasper S, Ebert B, Larsen K, Tonnoir B. Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 715-25. PMID 22008735 DOI: 10.1017/S146114571100112X |
0.33 |
|
| 2012 |
Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Papageorgiou K, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 259-66. PMID 21940152 DOI: 10.1016/j.euroneuro.2011.08.007 |
0.349 |
|
| 2012 |
Konstantinidis A, Papageorgiou K, Grohmann R, Horvath A, Engel R, Kasper S. Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 449-57. PMID 21733242 DOI: 10.1017/S1461145711000745 |
0.335 |
|
| 2012 |
Wulff K, Laigle L, Hajak G, Kasper S. P.2.c.025 Preliminary findings of the rest-activity cycles in patients with major depression following agomelatine and sertraline treatment European Neuropsychopharmacology. 22: S264-S265. DOI: 10.1016/S0924-977X(12)70398-X |
0.392 |
|
| 2012 |
Kranz G, Lanzenberger R, Haeusler D, Philippe C, Savli M, Hahn A, Mitterhauser M, Spindelegger C, Wadsak W, Kasper S. P.2.c.002 Prediction of SSRI treatment response in major depression based on serotonin transporter binding ratios European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70375-9 |
0.348 |
|
| 2012 |
Kranz G, Haeusler D, Akimova E, Savli M, Hahn A, Mitterhauser M, Spindelegger C, Wadsak W, Lanzenberger R, Kasper S. P.4.002 Serotonin transporter ratio between raphe nuclei and projection areas predicts SSRI treatment response in major depression European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70089-5 |
0.347 |
|
| 2012 |
Calati R, Massat I, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A. P.3.026 Clinical and genetic predictors of antidepressant response and remission in treatment-resistant depression European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70079-2 |
0.358 |
|
| 2012 |
Kraus C, Savli M, Hahn A, Höflich A, Baldinger P, Wadsak W, Windischberger C, Mitterhauser C, Kasper S, Lanzenberger R. P.1.029 Multimodal neuroimaging with PET and MRI to investigate the relation between serotonergic neurotransmission and regional brain volumes European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70030-5 |
0.351 |
|
| 2012 |
Kasper S. SOA03-01 - Understanding and treating depression European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)75663-8 |
0.415 |
|
| 2012 |
Schosser A, Calati R, Serretti A, Massat I, Papageorgiou K, Linotte S, Mendlewicz J, Souery D, Zohar J, Montgomery S, Kasper S. P-710 - The impact of BDNF gene polymorphisms on suicidality in treatment resistant major depressive disorder - a european multicenter study European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)74877-0 |
0.32 |
|
| 2012 |
Kasper S. CS02-01 - European program for treatment resistant depression (TRD) European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)74062-2 |
0.41 |
|
| 2012 |
Kasper S. AS25-01 - Depression: to switch or to combine? European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)74022-1 |
0.398 |
|
| 2011 |
Konstantinidis A, Martiny K, Bech P, Kasper S. A comparison of the Major Depression Inventory (MDI) and the Beck Depression Inventory (BDI) in severely depressed patients. International Journal of Psychiatry in Clinical Practice. 15: 56-61. PMID 22122690 DOI: 10.3109/13651501.2010.507870 |
0.405 |
|
| 2011 |
Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Möller HJ. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience. 261: 207-45. PMID 22033583 DOI: 10.1007/S00406-011-0259-6 |
0.422 |
|
| 2011 |
Aigner M, Treasure J, Kaye W, Kasper S. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 400-43. PMID 21961502 DOI: 10.3109/15622975.2011.602720 |
0.348 |
|
| 2011 |
Olajossy-Hilkesberger L, Godlewska B, Schosser-Haupt A, Olajossy M, Wojcierowski J, Landowski J, Marmurowska-Michałowska H, Kasper S. Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia. Neuropsychobiology. 64: 202-10. PMID 21912188 DOI: 10.1159/000327602 |
0.309 |
|
| 2011 |
Souery D, Zaninotto L, Calati R, Linotte S, Sentissi O, Amital D, Moser U, Kasper S, Zohar J, Mendlewicz J, Serretti A. Phenomenology of psychotic mood disorders: lifetime and major depressive episode features. Journal of Affective Disorders. 135: 241-50. PMID 21889213 DOI: 10.1016/j.jad.2011.07.027 |
0.406 |
|
| 2011 |
Scharinger C, Rabl U, Pezawas L, Kasper S. The genetic blueprint of major depressive disorder: contributions of imaging genetics studies. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 474-88. PMID 21830992 DOI: 10.3109/15622975.2011.596220 |
0.596 |
|
| 2011 |
Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak-Rieder N, Kasper S. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology. 64: 152-62. PMID 21811085 DOI: 10.1159/000328950 |
0.402 |
|
| 2011 |
Dold M, Aigner M, Lanzenberger R, Kasper S. [Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials]. Fortschritte Der Neurologie-Psychiatrie. 79: 453-66. PMID 21809258 DOI: 10.1055/s-0031-1273397 |
0.348 |
|
| 2011 |
Kasper S, Meshkat D, Kutzelnigg A. Improvement of the noradrenergic symptom cluster following treatment with milnacipran. Neuropsychiatric Disease and Treatment. 7: 21-7. PMID 21750625 DOI: 10.2147/NDT.S19615 |
0.36 |
|
| 2011 |
Souery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, Linotte S, Kasper S, Montgomery S, Zohar J, Mendlewicz J. Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 364-75. PMID 21718212 DOI: 10.3109/15622975.2011.590225 |
0.384 |
|
| 2011 |
Souery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, Linotte S, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Zohar J, Mendlewicz J. Switching antidepressant class does not improve response or remission in treatment-resistant depression. Journal of Clinical Psychopharmacology. 31: 512-6. PMID 21694617 DOI: 10.1097/JCP.0b013e3182228619 |
0.36 |
|
| 2011 |
Massat I, Kocabas NA, Crisafulli C, Chiesa A, Calati R, Linotte S, Kasper S, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, et al. COMT and age at onset in mood disorders: a replication and extension study. Neuroscience Letters. 498: 218-21. PMID 21600957 DOI: 10.1016/j.neulet.2011.05.012 |
0.313 |
|
| 2011 |
Hahn A, Stein P, Windischberger C, Weissenbacher A, Spindelegger C, Moser E, Kasper S, Lanzenberger R. Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder. Neuroimage. 56: 881-9. PMID 21356318 DOI: 10.1016/J.Neuroimage.2011.02.064 |
0.301 |
|
| 2011 |
Serretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, et al. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression. Psychiatry Research. 188: 166-9. PMID 21168919 DOI: 10.1016/j.psychres.2010.11.023 |
0.317 |
|
| 2011 |
Montgomery S, Hansen T, Kasper S. Efficacy of escitalopram compared to citalopram: a meta-analysis. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 261-8. PMID 20875220 DOI: 10.1017/S146114571000115X |
0.372 |
|
| 2011 |
Serretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Mendlewicz J. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. Journal of Affective Disorders. 128: 56-63. PMID 20643483 DOI: 10.1016/j.jad.2010.06.025 |
0.343 |
|
| 2011 |
Kasper S, Ebert B, Larsen K, Tonnoir B. P.2.d.012 Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70658-7 |
0.334 |
|
| 2011 |
Huf W, Kalcher K, Pail G, Boubela R, Pezawas L, Windischberger C, Moser E, Friedrich ME, Filzmoser P, Kasper S. P.2.c.020 Synthesising evidence in clinical psychopharmacology and beyond: a re-examination of published meta-analyses European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70634-4 |
0.569 |
|
| 2011 |
Baldinger P, Lanzenberger R, Hahn A, Mitterhauser M, Wadsak W, Micskei Z, Ungersböck J, Winkler D, Kasper S, Frey R. P.1.e.022 Effect of electroconvulsive therapy on serotonin-1A receptor binding in major depressive disorder European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70500-4 |
0.358 |
|
| 2011 |
Kalcher K, Pail G, Huf W, Scharinger C, Boubela R, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. S.07.04 Alterations of functional connectivity between basal ganglia and cortical regions during resting-state in remitted major depressive disorder European Neuropsychopharmacology. 21: S196. DOI: 10.1016/S0924-977X(11)70265-6 |
0.627 |
|
| 2011 |
Kalcher K, Pail G, Huf W, Scharinger C, Boubela R, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. P.3.016 Increased functional coupling between basal ganglia and cortical regions during resting state in remitted major depressive disorder European Neuropsychopharmacology. 21: S71-S72. DOI: 10.1016/S0924-977X(11)70084-0 |
0.635 |
|
| 2011 |
Scharinger C, Kasess C, Huf W, Kalcher K, Esterbauer H, Moser E, Sitte H, Kasper S, Pezawas L. P.1.033 Serotonin uptake in platelets predicts neural activation in the cingulate cortex European Neuropsychopharmacology. 21: S27. DOI: 10.1016/S0924-977X(11)70032-3 |
0.574 |
|
| 2011 |
Kasper S. U06-01 - Depression European Psychiatry. 26: 2186. DOI: 10.1016/S0924-9338(11)73889-5 |
0.394 |
|
| 2011 |
Kasper S, Vieta E, Bellivier F, Frye M. SS06-01 - Are we getting the most out of combination therapy in the short-term and long-term treatment of mania? European Psychiatry. 26: 2181-2181. DOI: 10.1016/S0924-9338(11)73884-6 |
0.366 |
|
| 2011 |
Kasper S. SS05-03 - Proven antidepressant efficacy of agomelatine against the full range of symptoms European Psychiatry. 26: 2179-2179. DOI: 10.1016/S0924-9338(11)73882-2 |
0.4 |
|
| 2011 |
Konstantinidis A, Grohmann R, Friedrich ME, Greil W, Kasper S. S05-02 - Bipolar treatment in everyday practice - the European perspective; data from the international AMSP program European Psychiatry. 26: 2027-2027. DOI: 10.1016/S0924-9338(11)73730-0 |
0.374 |
|
| 2011 |
Kasper S. S04-01 - Treatment Resistance in Depression European Psychiatry. 26: 2022-2022. DOI: 10.1016/S0924-9338(11)73725-7 |
0.396 |
|
| 2011 |
Kasper S. JS03-01 - Diagnosis and Treatment of Depression in Europe European Psychiatry. 26: 2003-2003. DOI: 10.1016/S0924-9338(11)73706-3 |
0.407 |
|
| 2011 |
Praschak-Rieder N, Willeit M, Sitte H, Meyer JH, Kasper S. FC29-05 - Season, sunlight, and brain serotonin function European Psychiatry. 26: 1981-1981. DOI: 10.1016/S0924-9338(11)73684-7 |
0.343 |
|
| 2011 |
Meshkat D, Kutzelnigg A, Eckert C, Konstantinidis A, Kasper S. FC25-04 - Comorbid mood and anxiety disorders in adult ADHD patients European Psychiatry. 26: 1956-1956. DOI: 10.1016/S0924-9338(11)73659-8 |
0.383 |
|
| 2011 |
Hahn A, Akimova E, Häusler D, Philippe C, Savli M, Baldinger P, Höflich A, Zgud S, Mitterhauser M, Wadsak W, Lanzenberger R, Kasper S. FC10-05 - Attenuated serotonin transporter association between midbrain and nucleus accumbens in major depression European Psychiatry. 26: 1868-1868. DOI: 10.1016/S0924-9338(11)73572-6 |
0.369 |
|
| 2011 |
Schosser A, Calati R, Serretti A, Massat I, Linotte S, Mendlewicz J, Souery D, Montgomery S, Kasper S. FC04-06 - Candidate gene association study of suicidality in treatment resistant MDD European Psychiatry. 26: 1833-1833. DOI: 10.1016/S0924-9338(11)73537-4 |
0.342 |
|
| 2011 |
Winkler D, Naderi-Heiden A, Strnad A, Winkler-Pjrek E, Scharfetter J, Kasper S, Frey R. P03-593 - The viennese psychiatric intensive care unit - diagnostic distribution European Psychiatry. 26: 1763-1763. DOI: 10.1016/S0924-9338(11)73467-8 |
0.352 |
|
| 2011 |
Kasper S, Fiorino MD, Montagnani G, Trespi G. P03-246 - Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in schizophrenic or schizoaffective patients European Psychiatry. 26: 1415-1415. DOI: 10.1016/S0924-9338(11)73120-0 |
0.401 |
|
| 2011 |
Naderi-Heiden A, Shadnia S, Salimi A-, Naderi A, Naderi MM, Schmid D, Gleiss A, Kasper S, Frey R. P03-99 - Antidepressant self-poisonings in iran European Psychiatry. 26: 1268-1268. DOI: 10.1016/S0924-9338(11)72973-X |
0.316 |
|
| 2011 |
Dold M, Aigner M, Lanzenberger R, Kasper S. P03-67 - Antipsychotics in obsessive-compulsive disorder - an auspicious approach for treatment-resistant patients? European Psychiatry. 26: 1236-1236. DOI: 10.1016/S0924-9338(11)72941-8 |
0.359 |
|
| 2011 |
Moser U, Savli M, Lanzenberger R, Kasper S. P02-553 - Database of MNI stereotactic coordinates for deep brain stimulation targets in neuropsychiatric disorders European Psychiatry. 26: 1149-1149. DOI: 10.1016/S0924-9338(11)72854-1 |
0.303 |
|
| 2011 |
Pail G, Scharinger C, Kalcher K, Huf W, Boubela R, Hartinger B, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. Remitted major depression is related to increased functional coupling between ventral striatum and cortical regions in resting state fMRI European Psychiatry. 26: 948-948. DOI: 10.1016/S0924-9338(11)72653-0 |
0.621 |
|
| 2011 |
Kranz G, Hahn A, Ungersböck J, Kaufmann U, Stein P, Baldinger P, Höflich A, Zgud S, Mitterhauser M, Wadsak W, Kasper S, Lanzenberger R. Cortisol plasma levels are associated with serotonin - 1A receptor binding in postmenopausal women European Psychiatry. 26: 933-933. DOI: 10.1016/S0924-9338(11)72638-4 |
0.337 |
|
| 2011 |
Kalcher K, Pail G, Huf W, Scharinger C, Boubela R, Hartinger B, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. Increased coupling of resting state activity between amygdala and cortical emotion processing regions in remitted major depressive disorder European Psychiatry. 26: 931-931. DOI: 10.1016/S0924-9338(11)72636-0 |
0.621 |
|
| 2011 |
Höflich AS, Philippe C, Savli M, Baldinger P, Kranz GS, Müller S, Häusler D, Zgud S, Kraus C, Wadsak W, Mitterhauser M, Lanzenberger R, Kasper S. P02-333 - Prediction of steady-state occupancy of the serotonin transporter based on single-dose occupancy: A [11C]DASB pet study European Psychiatry. 26: 929-929. DOI: 10.1016/S0924-9338(11)72634-7 |
0.345 |
|
| 2011 |
Fink M, Moser U, Pezawas L, Savli M, Stein P, Hahn A, Spindelegger C, Wadsak W, Windischberger C, Mitterhauser M, Kasper S, Lanzenberger R. Multimodal imaging of an astrocytoma affecting the amygdalar region European Psychiatry. 26: 924-924. DOI: 10.1016/S0924-9338(11)72629-3 |
0.625 |
|
| 2011 |
Boubela R, Kalcher K, Pail G, Huf W, Scharinger C, Hartinger B, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. Increased functional coupling between basalganglia and cingulate and prefrontal cortex during resting state conditions in remitted major depressive disorder European Psychiatry. 26: 915-915. DOI: 10.1016/S0924-9338(11)72620-7 |
0.626 |
|
| 2011 |
Scharinger C, Kasess C, Huf W, Kalcher K, Esterbauer H, Sitte H, Kasper S, Moser E, Pezawas L. P02-89 - Peripheral serotonin uptake is related to neural activation in the cingulate cortex European Psychiatry. 26: 684-684. DOI: 10.1016/S0924-9338(11)72390-2 |
0.596 |
|
| 2011 |
Hartinger B, Scharinger C, Diers K, Kasess C, Huf W, Kalcher K, Boubela R, Pail G, Brocke B, Kasper S, Moser E, Pezawas L. P02-38 - Biological alterations during remission of major depressive disorder European Psychiatry. 26: 633-633. DOI: 10.1016/S0924-9338(11)72339-2 |
0.655 |
|
| 2011 |
Sladky R, Kraus C, Tröstl J, Kasper S, Lanzenberger R, Moser E, Windischberger C. Orbitofrontal hyperactivity in social anxiety disorder patients: An fmri study European Psychiatry. 26: 179-179. DOI: 10.1016/S0924-9338(11)71890-9 |
0.309 |
|
| 2011 |
Kasper S, Gastpar SM, Müller WE, Volz HP, Möller HJ, Dienel A, Schläfke S. P01-160 - Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder European Psychiatry. 26: 160-160. DOI: 10.1016/S0924-9338(11)71871-5 |
0.343 |
|
| 2010 |
Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Dienel A, Schläfke S. Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials. Wiener Medizinische Wochenschrift (1946). 160: 547-56. PMID 21170695 DOI: 10.1007/s10354-010-0845-7 |
0.325 |
|
| 2010 |
Hahn A, Lanzenberger R, Wadsak W, Spindelegger C, Moser U, Mien LK, Mitterhauser M, Kasper S. Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 14482-9. PMID 20980606 DOI: 10.1523/JNEUROSCI.2409-10.2010 |
0.407 |
|
| 2010 |
Kasper S, Pail G. Milnacipran: a unique antidepressant? Neuropsychiatric Disease and Treatment. 6: 23-31. PMID 20856597 DOI: 10.2147/NDT.S11777 |
0.393 |
|
| 2010 |
Kocabas NA, Antonijevic I, Faghel C, Forray C, Kasper S, Lecrubier Y, Linotte S, Massat I, Montgomery S, Noro M, Oswald P, Snyder L, Souery D, Zohar J, Mendlewicz J. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 985-90. PMID 20822372 DOI: 10.3109/15622975.2010.512089 |
0.382 |
|
| 2010 |
Kasper S, Caraci F, Forti B, Drago F, Aguglia E. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 747-65. PMID 20708905 DOI: 10.1016/j.euroneuro.2010.07.005 |
0.367 |
|
| 2010 |
Mendlewicz J, Massat I, Linotte S, Kasper S, Konstantinidis A, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Souery D. Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study. International Clinical Psychopharmacology. 25: 297-301. PMID 20571412 DOI: 10.1097/YIC.0b013e32833c4ceb |
0.413 |
|
| 2010 |
Kasper S, Gastpar M, Möller HJ, Müller WE, Volz HP, Dienel A, Kieser M. Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression. International Clinical Psychopharmacology. 25: 204-13. PMID 20568656 DOI: 10.1097/Yic.0B013E328335Dc1A |
0.347 |
|
| 2010 |
Lanzenberger R, Wadsak W, Spindelegger C, Mitterhauser M, Akimova E, Mien LK, Fink M, Moser U, Savli M, Kranz GS, Hahn A, Kletter K, Kasper S. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1129-43. PMID 20519060 DOI: 10.1017/S1461145710000581 |
0.343 |
|
| 2010 |
Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Dienel A, Schläfke S. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial. International Clinical Psychopharmacology. 25: 277-87. PMID 20512042 DOI: 10.1097/YIC.0b013e32833b3242 |
0.308 |
|
| 2010 |
Noro M, Antonijevic I, Forray C, Kasper S, Kocabas NA, Lecrubier Y, Linotte S, Mendlewicz J, Montgomery S, Snyder L, Souery D, Verbanck P, Zohar J, Massat I. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder. International Clinical Psychopharmacology. 25: 228-31. PMID 20453658 DOI: 10.1097/YIC.0b013e328338bcf4 |
0.395 |
|
| 2010 |
Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. The Journal of Clinical Psychiatry. 71: 109-20. PMID 20193645 DOI: 10.4088/Jcp.09M05347Blu |
0.409 |
|
| 2010 |
Kaufmann RM, Kraft B, Frey R, Winkler D, Weiszenbichler S, Bäcker C, Kasper S, Kress HG. Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers. Pharmacopsychiatry. 43: 24-32. PMID 20178093 DOI: 10.1055/s-0029-1237397 |
0.308 |
|
| 2010 |
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 81-109. PMID 20148751 DOI: 10.3109/15622970903555881 |
0.385 |
|
| 2010 |
Kasper S, Montgomery SA, Möller HJ, van Oers HJ, Jan Schutte A, Vrijland P, van der Meulen EA. Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 36-44. PMID 20146649 DOI: 10.3109/15622970701691503 |
0.365 |
|
| 2010 |
Kranz GS, Kasper S, Lanzenberger R. Reward and the serotonergic system. Neuroscience. 166: 1023-35. PMID 20109531 DOI: 10.1016/j.neuroscience.2010.01.036 |
0.305 |
|
| 2010 |
Naderi-Heiden A, Naderi A, Naderi MM, Rahmani-Didar F, Salimi AR, Gleiss A, Kasper S, Frey R. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran. Pharmacopsychiatry. 43: 130-7. PMID 20101570 DOI: 10.1055/s-0029-1242820 |
0.311 |
|
| 2010 |
Windischberger C, Lanzenberger R, Holik A, Spindelegger C, Stein P, Moser U, Gerstl F, Fink M, Moser E, Kasper S. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage. 49: 1161-70. PMID 19833214 DOI: 10.1016/J.Neuroimage.2009.10.013 |
0.329 |
|
| 2010 |
Kasper S. How can guidelines help us in daily practice Annals of General Psychiatry. 9: 1-1. DOI: 10.1186/1744-859X-9-S1-S65 |
0.35 |
|
| 2010 |
Papageorgiou K, Konstantinidis A, Grohmann R, Horvath A, Engel R, Kasper S. P.2.g.005 Prescription of antipsychotics in inpatients with major depressive disorder in 2000 and 2007 – results from the AMSP pharmacovigilance project European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70610-6 |
0.36 |
|
| 2010 |
Akimova E, Lanzenberger R, Savli M, Häusler D, Wadsak W, Spindelegger C, Moser U, Fink M, Kletter K, Kasper S. P.2.c.037 The serotonin transporter (SERT) occupancy in median raphe nucleus quantified with PET predicts treatment response to SSRIs in major depressive disorder European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70552-6 |
0.384 |
|
| 2010 |
Kasess C, Scharinger C, Pail G, Uzelac Z, Freissmuth M, Kasper S, Moser E, Sitte H, Pezawas L. P.2.b.025 Serotonin uptake in blood platelets is related to cingulate cortex activation European Neuropsychopharmacology. 20: S367. DOI: 10.1016/S0924-977X(10)70515-0 |
0.568 |
|
| 2010 |
Huf W, Pail G, Hartinger B, Kasess C, Kasper S, Mattay V, Meyer-Lindenberg A, Moser E, Weinberger D, Pezawas L. P.1.e.015 Emotion cognition interaction located using surface-based versus volume-based analysis European Neuropsychopharmacology. 20: S296-S297. DOI: 10.1016/S0924-977X(10)70394-1 |
0.55 |
|
| 2010 |
Pail G, Huf W, Kasess C, Kasper S, Moser E, Brocke B, Meyer-Lindenberg A, Mattay V, Weinberger D, Pezawas L. P.1.e.011 Fronto-limbic interaction of working memory and emotion in the medial prefrontal cortex European Neuropsychopharmacology. 20: S294. DOI: 10.1016/S0924-977X(10)70390-4 |
0.557 |
|
| 2010 |
Stein P, Lanzenberger R, Kasper S. S.01.03 How antidepressants change emotional experience in depressed patients European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70118-8 |
0.328 |
|
| 2010 |
Akimova E, Lanzenberger R, Savli M, Häusler D, Wadsak W, Spindelegger C, Moser U, Fink M, Kletter K, Kasper S. P.3.001 Serotonin transporter (SERT) availability in raphe nuclei quantified with PET predicts treatment response to S-citalopram in major depressive disorder European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70073-0 |
0.379 |
|
| 2010 |
Montgomery S, Dell’Osso L, Kasper S, Pitchot W, Dencker-Vansvik E, Köhler J, Jörgensen L, Bauer M. P01-75 - Quetiapine XR or lithium combination with antidepressants in treatment resistant depression European Psychiatry. 25: 296. DOI: 10.1016/S0924-9338(10)70294-7 |
0.301 |
|
| 2010 |
Kasper S, Konstantinidis A. S26-01 - Antidepressant treatment: polypharmacy versus monotherapy European Psychiatry. 25: 8. DOI: 10.1016/S0924-9338(10)70008-0 |
0.41 |
|
| 2010 |
Kocabas NA, Forray C, Kasper S, Linotte S, Massat I, Mendlewicz J, Noro M, Oswald P, Zohar J, Souery D. Brain-derived neurotrophic factor (BDNF) gene polymorphisms: Influence on treatment response phenotypes of major depressive disorder Toxicology Letters. 196. DOI: 10.1016/J.Toxlet.2010.03.376 |
0.363 |
|
| 2009 |
Kasper S. 9(th) International Forum on Mood and Anxiety Disorders. International Journal of Psychiatry in Clinical Practice. 13: 6-22. PMID 24922315 DOI: 10.3109/13651500903375487 |
0.301 |
|
| 2009 |
Kasper S, Herman B, Nivoli G, Van Ameringen M, Petralia A, Mandel FS, Baldinetti F, Bandelow B. Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. International Clinical Psychopharmacology. 24: 87-96. PMID 21456104 DOI: 10.1097/Yic.0B013E32831D7980 |
0.324 |
|
| 2009 |
Naderi-Heiden A, Shadnia S, Salimi AR, Naderi A, Naderi MM, Schmid D, Gleiss A, Kasper S, Frey R. Self-poisonings with tricyclic antidepressants and selective serotonin reuptake inhibitors in Tehran, Iran. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 302-12. PMID 19921972 DOI: 10.3109/15622970802288563 |
0.314 |
|
| 2009 |
Schosser A, Kasper S. The role of pharmacogenetics in the treatment of depression and anxiety disorders. International Clinical Psychopharmacology. 24: 277-88. PMID 19738481 DOI: 10.1097/YIC.0b013e3283306a2f |
0.408 |
|
| 2009 |
Feldmann RE, Kranz G, Praschak-Rieder N, Kasper S. Psycho-pharmacotherapy for anxiety and obsessive-compulsive disorder: the issue of prolonged barbiturate retention. Current Medical Research and Opinion. 25: 2281-5. PMID 19630487 DOI: 10.1185/03007990903116172 |
0.319 |
|
| 2009 |
Serretti A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Sens-Espel R, Bollen J, Zohar J, Berlo J, Lienard P, De Ronchi D, Mendlewicz J, Souery D. Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients. International Clinical Psychopharmacology. 24: 250-6. PMID 19593158 DOI: 10.1097/YIC.0b013e32832e5b0d |
0.331 |
|
| 2009 |
Kasper S. The psychiatrist confronted with a fibromyalgia patient. Human Psychopharmacology. 24: S25-30. PMID 19479904 DOI: 10.1002/hup.1027 |
0.378 |
|
| 2009 |
Akimova E, Lanzenberger R, Kasper S. The serotonin-1A receptor in anxiety disorders. Biological Psychiatry. 66: 627-35. PMID 19423077 DOI: 10.1016/j.biopsych.2009.03.012 |
0.34 |
|
| 2009 |
Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R. Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. International Clinical Psychopharmacology. 24: 119-25. PMID 19367152 DOI: 10.1097/YIC.0b013e32832a8ec8 |
0.325 |
|
| 2009 |
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 85-116. PMID 19347775 DOI: 10.1080/15622970902823202 |
0.304 |
|
| 2009 |
Kasper S, Hamon M. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 117-26. PMID 19255935 DOI: 10.1080/15622970902717024 |
0.402 |
|
| 2009 |
Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of Psychiatric Research. 43: 792-7. PMID 19230909 DOI: 10.1016/j.jpsychires.2008.11.004 |
0.375 |
|
| 2009 |
Kasper S, Baldwin DS, Larsson Lönn S, Boulenger JP. Superiority of escitalopram to paroxetine in the treatment of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 229-37. PMID 19185467 DOI: 10.1016/j.euroneuro.2008.12.003 |
0.427 |
|
| 2009 |
Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial. Journal of Psychiatric Research. 43: 702-10. PMID 19038406 DOI: 10.1016/J.Jpsychires.2008.10.004 |
0.387 |
|
| 2009 |
Spindelegger C, Lanzenberger R, Wadsak W, Mien LK, Stein P, Mitterhauser M, Moser U, Holik A, Pezawas L, Kletter K, Kasper S. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Molecular Psychiatry. 14: 1040-50. PMID 18362913 DOI: 10.1038/mp.2008.35 |
0.602 |
|
| 2009 |
Hahn A, Lanzenberger R, Spindelegger C, Stein P, Mien L, Savli M, Akimova E, Mitterhauser M, Wadsak W, Kasper S. Enhanced association of pre- to postsynaptic serotonin-1A receptors through escitalopram treatment in anxiety disorder patients Pharmacopsychiatry. 42. DOI: 10.1055/S-0029-1240124 |
0.339 |
|
| 2009 |
Savli M, Akimova E, Häusler D, Moser U, Fink M, Hahn A, Mitterhauser M, Wadsak W, Lanzenberger R, Kasper S. Age-related Change of Serotonin Transporter Binding in Major Depressive Disorder Neuroimage. 47: S49. DOI: 10.1016/S1053-8119(09)70108-9 |
0.353 |
|
| 2009 |
Hahn A, Lanzenberger R, Fink M, Stein P, Mien LK, Savli M, Ammova E, Mitterhauser M, Wadsak W, Kasper S. P.4.c.007 Effect of escitalopram treatment on the relationship of pre- to postsynaptic serotonin-1A receptors in anxiety disorders European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70975-7 |
0.321 |
|
| 2009 |
Akimova E, Savli M, Haeusler D, Fink M, Hahn A, Wadsak W, Mitterhauser M, Lanzenberger R, Kletter K, Kasper S. P.2.c.036 Increase of 5-HTT occupancy during escitalopram or citalopram treatment correlates with antidepressant efficacy in major depressive disorder European Neuropsychopharmacology. 19: S424-S425. DOI: 10.1016/S0924-977X(09)70658-3 |
0.401 |
|
| 2009 |
Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D. P.2.c.002 Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70624-8 |
0.314 |
|
| 2009 |
Kasper S. SOA02-01 Neuroimaging findings and diagnosis European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70361-X |
0.358 |
|
| 2009 |
Kasper S. CS07-03 Pharmacological properties of psychopharmaca in relationship to their clinical indications European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70330-X |
0.411 |
|
| 2008 |
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 9: 248-312. PMID 18949648 DOI: 10.1080/15622970802465807 |
0.361 |
|
| 2008 |
Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 803-13. PMID 18694635 DOI: 10.1016/j.euroneuro.2008.06.006 |
0.388 |
|
| 2008 |
Kasper S. Everyday problems in treating depression: focus on SNRIs. Introduction. Cns Spectrums. 13: 4. PMID 18622367 DOI: 10.1017/S1092852900028248 |
0.331 |
|
| 2008 |
Stein P, Savli M, Wadsak W, Mitterhauser M, Fink M, Spindelegger C, Mien LK, Moser U, Dudczak R, Kletter K, Kasper S, Lanzenberger R. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. European Journal of Nuclear Medicine and Molecular Imaging. 35: 2159-68. PMID 18542956 DOI: 10.1007/s00259-008-0850-x |
0.301 |
|
| 2008 |
Kasper S. Do we need another atypical antipsychotic? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: S146-52. PMID 18511242 DOI: 10.1016/j.euroneuro.2008.04.006 |
0.31 |
|
| 2008 |
Pjrek E, Willeit M, Praschak-Rieder N, Konstantinidis A, Semlitsch HV, Kasper S, Winkler D. Treatment of seasonal affective disorder with duloxetine: an open-label study. Pharmacopsychiatry. 41: 100-5. PMID 18484551 DOI: 10.1055/s-2008-1058103 |
0.348 |
|
| 2008 |
Kasper S, Gastpar M, Müller WE, Volz HP, Dienel A, Kieser M, Möller HJ. Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. European Archives of Psychiatry and Clinical Neuroscience. 258: 59-63. PMID 18084790 DOI: 10.1007/s00406-007-0779-2 |
0.336 |
|
| 2008 |
Kasper S, McEwen BS. Neurobiological and clinical effects of the antidepressant tianeptine. Cns Drugs. 22: 15-26. PMID 18072812 DOI: 10.2165/00023210-200822010-00002 |
0.365 |
|
| 2008 |
Willeit M, Sitte HH, Thierry N, Michalek K, Praschak-Rieder N, Zill P, Winkler D, Brannath W, Fischer MB, Bondy B, Kasper S, Singer EA. Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1503-13. PMID 17882235 DOI: 10.1038/Sj.Npp.1301560 |
0.39 |
|
| 2008 |
Papakostas GI, Nelson JC, Kasper S, Möller HJ. A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 122-7. PMID 17719752 DOI: 10.1016/j.euroneuro.2007.07.005 |
0.397 |
|
| 2008 |
Chourbaji S, Brandwein C, Gau D, Depner M, Saam C, Johansson C, Schalling M, Partonen T, Kasper S, Adolfsson R, Urani A, Lemberger T, Schütz G, Schumann G, Gass P. CREB-regulated diurnal activity patterns are not indicative for depression-like symptoms in mice and men. Medical Hypotheses. 70: 117-21. PMID 17574346 DOI: 10.1016/j.mehy.2007.04.018 |
0.33 |
|
| 2008 |
Kasper S, Baldwin D, Boulenger J. P.2.a.009 Pooled analysis: 2 randomised clinical trials confirms superiority of escitalopram over paroxetine in treatment of major depressive disorder European Neuropsychopharmacology. 18: S297-S298. DOI: 10.1016/S0924-977X(08)70398-5 |
0.413 |
|
| 2008 |
Kocabas NA, Faghel C, Barreto M, Linotte S, Souery D, Kasper S, Zohar J, Mendlewicz J, Massat I. The impact of catechol-O-methyltransferase (COMT) pharmacogenetics on treatment resistance in major depressive disorder detected by capillary electrophoresis Toxicology Letters. 180. DOI: 10.1016/J.Toxlet.2008.06.375 |
0.355 |
|
| 2007 |
Peuskens J, Kasper S, Arango C, Bandinelli PL, Gastpar M, Keks N, Mitchell S, Oral T, Timdahl K, Vieta E. Management of acutely ill patients in the hospital setting: focus on quetiapine. International Journal of Psychiatry in Clinical Practice. 11: 61-72. PMID 24941277 DOI: 10.1080/13651500601168291 |
0.325 |
|
| 2007 |
Montgomery SA, Baldwin DS, Blier P, Fineberg NA, Kasper S, Lader M, Lam RW, Lépine JP, Möller HJ, Nutt DJ, Rouillon F, Schatzberg AF, Thase ME. Which antidepressants have demonstrated superior efficacy? A review of the evidence. International Clinical Psychopharmacology. 22: 323-9. PMID 17917550 DOI: 10.1097/Yic.0B013E3282Eff7E0 |
0.403 |
|
| 2007 |
Pjrek E, Winkler D, Praschak-Rieder N, Willeit M, Stastny J, Konstantinidis A, Kasper S. Season of birth in siblings of patients with seasonal affective disorder. A test of the parental conception habits hypothesis. European Archives of Psychiatry and Clinical Neuroscience. 257: 378-82. PMID 17902009 DOI: 10.1007/s00406-007-0720-8 |
0.318 |
|
| 2007 |
Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M. Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode. Wiener Medizinische Wochenschrift (1946). 157: 362-6. PMID 17704988 DOI: 10.1007/s10354-007-0441-7 |
0.323 |
|
| 2007 |
Montgomery SA, Kasper S. Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine. International Clinical Psychopharmacology. 22: 283-91. PMID 17690597 DOI: 10.1097/YIC.0b013e3280c56b13 |
0.383 |
|
| 2007 |
Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Mendlewicz J. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. The Journal of Clinical Psychiatry. 68: 1062-70. PMID 17685743 DOI: 10.4088/JCP.V68N0713 |
0.403 |
|
| 2007 |
Oswald P, Souery D, Kasper S, Lecrubier Y, Montgomery S, Wyckaert S, Zohar J, Mendlewicz J. Current issues in bipolar disorder: a critical review. European Neuropsychopharmacology. 17: 687-695. PMID 17513092 DOI: 10.1016/J.Euroneuro.2007.03.006 |
0.333 |
|
| 2007 |
Olié JP, Kasper S. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. The International Journal of Neuropsychopharmacology. 10: 661-673. PMID 17477888 DOI: 10.1017/S1461145707007766 |
0.408 |
|
| 2007 |
Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, Aron L, Rietschel M, Wellek S, Soronen P, Paunio T, Koch A, Chen P, Lathrop M, Adolfsson R, ... ... Kasper S, et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Annals of Medicine. 39: 229-38. PMID 17457720 DOI: 10.1080/07853890701278795 |
0.336 |
|
| 2007 |
Robert PH, Michel E, Van Os J, Altamura AC, Bobes J, Gerlach J, Hellewell JS, Kasper S, Nabel D. [2-COM: presentation of an instrument facilitating communication between physicians and carers in daily practice]. L'Encephale. 33: 60-4. PMID 17457295 DOI: 10.1016/S0013-7006(07)91559-6 |
0.305 |
|
| 2007 |
Winkler D, Pjrek E, Moser U, Kasper S. Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria. Human Psychopharmacology-Clinical and Experimental. 22: 245-251. PMID 17443491 DOI: 10.1002/Hup.839 |
0.351 |
|
| 2007 |
Pjrek E, Winkler D, Stastny J, Praschak-Rieder N, Willeit M, Kasper S. Escitalopram in seasonal affective disorder: results of an open trial. Pharmacopsychiatry. 40: 20-24. PMID 17327956 DOI: 10.1055/S-2007-958718 |
0.405 |
|
| 2007 |
Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, Kasper S. Agomelatine in the treatment of seasonal affective disorder. Psychopharmacology. 190: 575-579. PMID 17171557 DOI: 10.1007/S00213-006-0645-3 |
0.333 |
|
| 2007 |
Kudla D, Lambert M, Domin S, Kasper S, Naber D. Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial. European Psychiatry. 22: 195-202. PMID 17140769 DOI: 10.1016/J.Eurpsy.2006.06.004 |
0.323 |
|
| 2007 |
Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien L, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J. Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder Biological Psychiatry. 61: 1081-1089. PMID 16979141 DOI: 10.1016/J.Biopsych.2006.05.022 |
0.344 |
|
| 2007 |
Kasper S, Möller H. Editorial: Paving the way to remission: the melatonergic approach in depression International Clinical Psychopharmacology. 22: v. DOI: 10.1097/01.YIC.0000277960.68228.54 |
0.34 |
|
| 2007 |
Spindelegger C, Lanzenberger R, Mitterhauser M, Mien LK, Stein P, Wadsak W, Moser U, Holik A, Kletter K, Kasper S. P.4.b.011 Decrease in serotonin-1A receptor binding correlates with reduced anxiety scores after 12-week SSRI treatment European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70795-2 |
0.306 |
|
| 2007 |
Winkler D, Pjrek E, Willeit M, Praschak-Rieder N, Konstantinidis A, Kasper S. P.2.c.011 Escitalopram versus reboxetine in the treatment of seasonal affective disorder European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70503-5 |
0.316 |
|
| 2007 |
Wulff K, Bayle F, Hajak G, Montejo Gonzales A, Smeraldi E, Rybakowski J, Laigle L, Kasper S. P.2.a.025 Exploratory study of actigraphic and psychometric measures in depressed patients treated with agomelatine or sertraline European Neuropsychopharmacology. 17: S326. DOI: 10.1016/S0924-977X(07)70467-4 |
0.382 |
|
| 2007 |
Spindelegger CJ, Lanzenberger R, Mitterhauser M, Mien LK, Stein P, Wadsak W, Moser U, Holik A, Kletter K, Kasper S. S.07.06 Changes in serotonin-1A receptor binding after long-term treatment with escitalopram in patients with anxiety disorders European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70202-X |
0.326 |
|
| 2007 |
Mendlewicz J, Oswald P, Massat I, Bailler G, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Souery D. S.02.05 European research programme on treatment resistant depression European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70177-3 |
0.322 |
|
| 2007 |
Kasper S. Long-term treatment of unipolar depression European Psychiatry. 22. DOI: 10.1016/J.Eurpsy.2007.01.280 |
0.35 |
|
| 2007 |
Souery D, Oswald P, Massat I, Bailler U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Mendlewicz J. Factors associated to resistant depression European Psychiatry. 22: S69. DOI: 10.1016/J.EURPSY.2007.01.265 |
0.319 |
|
| 2006 |
Lee M, Lim S, Cha J, Chung S, Kim K, Kasper S. The Korean Medication Algorithm for Major Depressive Disorder (KMA-MDD): Report of the Korean Society of Depressive and Bipolar Disorders. International Journal of Psychiatry in Clinical Practice. 10: 186-194. PMID 24941057 DOI: 10.1080/13651500600633584 |
0.329 |
|
| 2006 |
Kasper S. Anxiety disorders: under-diagnosed and insufficiently treated International Journal of Psychiatry in Clinical Practice. 10: 3-9. PMID 24931537 DOI: 10.1080/13651500600552297 |
0.321 |
|
| 2006 |
Kasper S, Lemming OM, Swart Hd. Escitalopram in the long-term treatment of major depressive disorder in elderly patients. Neuropsychobiology. 54: 152-159. PMID 17230032 DOI: 10.1159/000098650 |
0.389 |
|
| 2006 |
Klein N, Sacher J, Geiss-Granadia T, Attarbaschi T, Mossaheb N, Lanzenberger R, Pötzi C, Holik A, Spindelegger C, Asenbaum S, Dudczak R, Tauscher J, Kasper S. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology. 188: 263-272. PMID 16955282 DOI: 10.1007/S00213-006-0486-0 |
0.35 |
|
| 2006 |
Kasper S. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms. European Neuropsychopharmacology. 16. PMID 16872809 DOI: 10.1016/J.Euroneuro.2006.06.004 |
0.315 |
|
| 2006 |
Montgomery SA, Tobias K, Zornberg GL, Kasper S, Pande AC. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. The Journal of Clinical Psychiatry. 67: 771-82. PMID 16841627 DOI: 10.4088/jcp.v67n0511 |
0.334 |
|
| 2006 |
Winkler D, Pjrek E, Iwaki R, Kasper S. Treatment of seasonal affective disorder. Expert Review of Neurotherapeutics. 6: 1039-1048. PMID 16831117 DOI: 10.1586/14737175.6.7.1039 |
0.388 |
|
| 2006 |
Mühlbacher M, Konstantinidis A, Kasper S, Eichberger G, Hinterhuber H, Hofmann P, Nimmerrichter A, Schubert H, Egger C, Nickel M, Stuppaeck C. Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients. Neuropsychobiology. 53: 83-7. PMID 16511339 DOI: 10.1159/000091724 |
0.401 |
|
| 2006 |
Winkler D, Pjrek E, Kindler J, Heiden A, Kasper S. Validation of a Simplified Definition of Anger Attacks Psychotherapy and Psychosomatics. 75: 103-106. PMID 16508345 DOI: 10.1159/000090894 |
0.333 |
|
| 2006 |
Kasper S, Spadone C, Verpillat P, Angst J. Onset of action of escitalopram compared with other antidepressants : results of a pooled analysis International Clinical Psychopharmacology. 21: 105-110. PMID 16421462 DOI: 10.1097/01.Yic.0000194375.42589.C3 |
0.406 |
|
| 2006 |
Kasper S. WFSBP Guidelines for Biological Treatment of Bipolar Disorders Part I - Treatment of Bipolar Depression European Neurological Review. 77. DOI: 10.17925/Enr.2006.00.01.77 |
0.378 |
|
| 2006 |
Oswald P, Souery D, Kasper S, Lecrubier Y, Montgomery SA, Zohar J, Mendlewicz J. Predictive factors of resistance to antidepressants in bipolar depression: results from a European multicentre study European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)80098-2 |
0.333 |
|
| 2006 |
Pjrek E, Winkler D, Konstantinidis A, Stastny J, Willeit M, Praschak-Rieder N, Kasper S. Explaining birth seasonality in fall-winter depression: idiosyncratic procreational patterns in the patients' parents European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)80047-7 |
0.309 |
|
| 2006 |
Moser U, Spindelegger CJ, Lanzenberger R, Mien LK, Mitterhauser M, Wadsak W, Klein N, Attarbaschi T, Holik A, Mossaheb N, Sacher J, Kletter K, Kasper S. P.1.e.008 Hypothalamic decrease in serotonin1A receptor binding indicating disturbances in the hypothalamic-pituitary-gonadal axis in anxiety disorders European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70243-7 |
0.301 |
|
| 2005 |
Pezawas L, Angst J, Kasper S. Recurrent brief depression revisited. International Review of Psychiatry (Abingdon, England). 17: 63-70. PMID 16194772 DOI: 10.1080/00207390500064650 |
0.658 |
|
| 2005 |
Letmaier M, Schreinzer D, Reinfried L, Glauninger G, Thierry N, Kapitany T, Kasper S. Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting. The International Journal of Neuropsychopharmacology. 9: 529-37. PMID 16191207 DOI: 10.1017/S1461145705006073 |
0.359 |
|
| 2005 |
Winkler D, Pjrek E, Praschak-Rieder N, Willeit M, Pezawas L, Konstantinidis A, Stastny J, Kasper S. Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biological Psychiatry. 58: 331-6. PMID 16102546 DOI: 10.1016/j.biopsych.2005.01.031 |
0.603 |
|
| 2005 |
Winkler D, Pjrek E, Kasper S. Anger attacks in depression--evidence for a male depressive syndrome. Psychotherapy and Psychosomatics. 74: 303-307. PMID 16088268 DOI: 10.1159/000086321 |
0.347 |
|
| 2005 |
Kasper S, Olivieri L, Loreto GD, Dionisio P. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder Current Medical Research and Opinion. 21: 1139-1146. PMID 16083521 DOI: 10.1185/030079905X53243 |
0.366 |
|
| 2005 |
Pjrek E, Winkler D, Kasper S. Pharmacotherapy of Seasonal Affective Disorder Cns Spectrums. 10: 664-669. PMID 16041297 DOI: 10.1017/S1092852900019623 |
0.38 |
|
| 2005 |
Winkler D, Pjrek E, Konstantinidis A, Praschak-Rieder N, Willeit M, Stastny J, Kasper S. Anger attacks in seasonal affective disorder The International Journal of Neuropsychopharmacology. 9: 215-219. PMID 16004620 DOI: 10.1017/S1461145705005602 |
0.396 |
|
| 2005 |
Heiden A, Kettenbach J, Fischer P, Schein B, Ba-Ssalamah A, Frey R, Naderi MM, Gulesserian T, Schmid D, Trattnig S, Imhof H, Kasper S. White matter hyperintensities and chronicity of depression. Journal of Psychiatric Research. 39: 285-93. PMID 15725427 DOI: 10.1016/j.jpsychires.2004.07.004 |
0.356 |
|
| 2005 |
Adam D, Kasper S, Möller H-, Singer EA. Placebo-controlled trials in major depression are necessary and ethically justifiable: how to improve the communication between researchers and ethical committees. European Archives of Psychiatry and Clinical Neuroscience. 255: 258-260. PMID 15611842 DOI: 10.1007/S00406-004-0555-5 |
0.322 |
|
| 2005 |
Bailer U, Wiesegger G, Leisch F, Fuchs K, Leitner I, Letmaier M, Konstantinidis A, Stastny J, Sieghart W, Hornik K, Mitterauer B, Kasper S, Aschauer HN. No association of clock gene T3111C polymorphism and affective disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 15: 51-5. PMID 15572273 DOI: 10.1016/j.euroneuro.2004.05.004 |
0.336 |
|
| 2005 |
Kasper S, Swart Hd, Andersen HF. Escitalopram in the treatment of depressed elderly patients. American Journal of Geriatric Psychiatry. 13: 884-891. DOI: 10.1097/00019442-200510000-00008 |
0.367 |
|
| 2005 |
Steiger A, Künzel HE, Uhr M, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A. Trimipramine is equivalent to combined treatment with amitriptyline and haloperidol in patients with delusional depression Pharmacopsychiatry. 38: 279-279. DOI: 10.1055/S-2005-918846 |
0.319 |
|
| 2005 |
Kasper S, Pezawas L. Will atypical antipsychotics play a role in phase prophylaxis? Pharmacopsychiatry. 38. DOI: 10.1055/s-2005-918732 |
0.539 |
|
| 2005 |
Dienel A, Kasper S, Kieser M. Hypericum extract WS® 5570 has a beneficial effect in continuation treatment of recurrent depression Pharmacopsychiatry. 38. DOI: 10.1055/S-2005-918661 |
0.344 |
|
| 2004 |
Kasper S. Unique mechanism of action for escitalopram: does it hold the promise? International Journal of Psychiatry in Clinical Practice. 8: 15-18. PMID 24930684 DOI: 10.1080/13651500410005504 |
0.362 |
|
| 2004 |
Stein DJ, Kasper S, Andersen EW, Nil R, Lader M. Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions. Depression and Anxiety. 20: 175-181. PMID 15643634 DOI: 10.1002/Da.20043 |
0.357 |
|
| 2004 |
Klein N, Sacher J, Wallner H, Tauscher J, Kasper S. Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics. Cns Spectrums. 9: 823-832. PMID 15520606 DOI: 10.1017/S1092852900002248 |
0.367 |
|
| 2004 |
Pjrek E, Winkler D, Heiden A, Praschak-Rieder N, Willeit M, Konstantinidis A, Stastny J, Kasper S. Seasonality of birth in seasonal affective disorder. The Journal of Clinical Psychiatry. 65: 1389-1393. PMID 15491243 DOI: 10.4088/Jcp.V65N1014 |
0.368 |
|
| 2004 |
Hirschfeld RMA, Kasper S. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. The International Journal of Neuropsychopharmacology. 7: 507-522. PMID 15458610 DOI: 10.1017/S1461145704004651 |
0.348 |
|
| 2004 |
Winkler D, Pjrek E, Heiden A, Wiesegger G, Klein N, Konstantinidis A, Kasper S. Gender differences in the psychopathology of depressed inpatients. European Archives of Psychiatry and Clinical Neuroscience. 254: 209-214. PMID 15309388 DOI: 10.1007/S00406-004-0471-8 |
0.367 |
|
| 2004 |
Kasper S, Dienel A, Kieser M. Continuation and long‐term maintenance treatment with Hypericum extract WS® 5570 after successful acute treatment of mild to moderate depression – rationale and study design International Journal of Methods in Psychiatric Research. 13: 176-183. PMID 15297901 DOI: 10.1002/Mpr.173 |
0.386 |
|
| 2004 |
Kasper S, Brecher M, Fitton L, Jones AM. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia. International Clinical Psychopharmacology. 19: 281-289. PMID 15289701 DOI: 10.1097/01.Yic.0000138822.62874.Fd |
0.306 |
|
| 2004 |
Hemels ME, Kasper S, Walter E, Einarson TR. Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria. Current Medical Research and Opinion. 20: 869-78. PMID 15200745 DOI: 10.1185/030079904125003737 |
0.328 |
|
| 2004 |
Pjrek E, Winkler D, Stastny J, Konstantinidis A, Heiden A, Kasper S. Bright light therapy in seasonal affective disorder - does it suffice? European Neuropsychopharmacology. 14: 347-351. PMID 15163447 DOI: 10.1016/J.Euroneuro.2003.11.003 |
0.401 |
|
| 2004 |
Calabrese JR, Kasper S, Johnson G, Tajima O, Vieta E, Yatham LN, Young AH. International Consensus Group on Bipolar I Depression Treatment Guidelines. The Journal of Clinical Psychiatry. 65: 571-9. PMID 15119923 DOI: 10.4088/Jcp.V65N0419 |
0.381 |
|
| 2004 |
Hemels ME, Kasper S, Walter E, Einarson TR. Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression. The Annals of Pharmacotherapy. 38: 954-60. PMID 15113989 DOI: 10.1345/aph.1E010 |
0.344 |
|
| 2004 |
Bailer U, Zwaan Md, Leisch F, Strnad A, Lennkh-Wolfsberg C, El-Giamal N, Hornik K, Kasper S. Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosa. International Journal of Eating Disorders. 35: 522-537. PMID 15101068 DOI: 10.1002/Eat.20003 |
0.332 |
|
| 2004 |
Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. The Journal of Clinical Psychiatry. 65: 432-41. PMID 15096085 DOI: 10.4088/JCP.V65N0321 |
0.385 |
|
| 2004 |
Letmaier M, Schreinzer D, Thierry N, Wolf R, Kasper S. [Drug therapy of acute manias. A retrospective data analysis of inpatients from 1997 to 1999]. Der Nervenarzt. 75: 249-57. PMID 15021926 DOI: 10.1007/S00115-003-1554-X |
0.309 |
|
| 2004 |
Pjrek E, Winkler D, Willeit M, Konstantinidis A, Thierry N, Kasper S. Menstrual disturbances a rare side-effect of bright-light therapy. The International Journal of Neuropsychopharmacology. 7: 239-240. PMID 14962352 DOI: 10.1017/S1461145703003997 |
0.364 |
|
| 2004 |
Moscovitch A, Blashko CA, Eagles JM, Darcourt G, Thompson C, Kasper S, Lane RM. A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology. 171: 390-7. PMID 14504682 DOI: 10.1007/s00213-003-1594-8 |
0.396 |
|
| 2004 |
Linotte S, Oswald P, Massat I, Souery D, Kasper S, Lecrubier Y, Zohar J, Mendlewicz J. P.3.02 Personality traits as predictors of treatment response in patient with affective disorder European Neuropsychopharmacology. 14. DOI: 10.1016/S0924-977X(04)90057-0 |
0.329 |
|
| 2004 |
Attarbaschi T, Geiss-Granadia T, Sacher J, Klein N, Mossaheb N, Wiesegger G, Lanzenberger R, Asenbaum S, Dudczak R, Kasper S, Tauscher J. P.3.19 Quantification of striatal D2 receptoroccupancy in bipolar patients treated with olanzapine using [123I] lodobenzamide and SPECT European Neuropsychopharmacology. 14. DOI: 10.1016/S0924-977X(04)80330-4 |
0.306 |
|
| 2004 |
Oswaki P, Souery D, Kasper S, Lecrubier Y, Zohar I, Mendlemicz I. P.1.095 Unipolar and bipolar depression: Demographic and clinical differences. Results from a European multicenter study European Neuropsychopharmacology. 14. DOI: 10.1016/S0924-977X(04)80184-6 |
0.388 |
|
| 2003 |
Kasper S. Treatment of depressive symptoms with quetiapine. Expert Review of Neurotherapeutics. 3: 417-423. PMID 19810926 DOI: 10.1586/14737175.3.4.417 |
0.377 |
|
| 2003 |
Winkler D, Pjrek E, Pezawas L, Presslich O, Tauscher J, Kasper S. Relationship between power spectra of the awake EEG and psychomotor activity patterns measured by short-term actigraphy. Neuropsychobiology. 48: 176-81. PMID 14673214 DOI: 10.1159/000074634 |
0.561 |
|
| 2003 |
Kasper S, Lerman MN, McQuade RD, Saha A, Carson WH, Ali M, Archibald D, Ingenito G, Marcus R, Pigott T. Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 6: 325-37. PMID 14609439 DOI: 10.1017/S1461145703003651 |
0.309 |
|
| 2003 |
Willeit M, Praschak-Rieder N, Neumeister A, Zill P, Leisch F, Stastny J, Hilger E, Thierry N, Konstantinidis A, Winkler D, Fuchs K, Sieghart W, Aschauer H, Ackenheil M, Bondy B, ... Kasper S, et al. A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Molecular Psychiatry. 8: 942-6. PMID 14593433 DOI: 10.1038/sj.mp.4001392 |
0.356 |
|
| 2003 |
Kasper S. Issues in the treatment of bipolar disorder European Neuropsychopharmacology. 13: 37-42. PMID 12957718 DOI: 10.1016/S0924-977X(03)00076-2 |
0.423 |
|
| 2003 |
Leitner I, Praschak-Rieder N, Willeit M, Kasper S. Quetiapine in a delusional depressed elderly patient: no EPS and a favourable outcome. The International Journal of Neuropsychopharmacology. 6: 199-200. PMID 12890313 DOI: 10.1017/S1461145703003328 |
0.335 |
|
| 2003 |
Johansson C, Willeit M, Levitan R, Partonen T, Smedh C, Del Favero J, Bel Kacem S, Praschak-Rieder N, Neumeister A, Masellis M, Basile V, Zill P, Bondy B, Paunio T, Kasper S, et al. The serotonin transporter promoter repeat length polymorphism, seasonal affective disorder and seasonality. Psychological Medicine. 33: 785-92. PMID 12877393 DOI: 10.1017/S0033291703007372 |
0.316 |
|
| 2003 |
Gruber S, Frey R, Mlynarik V, Stadlbauer A, Heiden A, Kasper S, Kemp GJ, Moser E. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Investigative Radiology. 38: 403-408. PMID 12821853 DOI: 10.1097/01.Rli.0000073446.43445.20 |
0.321 |
|
| 2003 |
Pezawas L, Wittchen HU, Pfister H, Angst J, Lieb R, Kasper S. Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adults. Psychological Medicine. 33: 407-18. PMID 12701662 DOI: 10.1017/S0033291702006967 |
0.637 |
|
| 2003 |
Baldwin D, Broich K, Fritze J, Kasper S, Westenberg H, Möller H. Placebo-controlled studies in depression: necessary, ethical and feasible European Archives of Psychiatry and Clinical Neuroscience. 253: 22-28. PMID 12664309 DOI: 10.1007/S00406-003-0400-2 |
0.367 |
|
| 2003 |
El-Giamal N, Zwaan Md, Bailer U, Strnad A, Schüssler P, Kasper S. Milnacipran in the treatment of bulimia nervosa: a report of 16 cases. European Neuropsychopharmacology. 13: 73-79. PMID 12650949 DOI: 10.1016/S0924-977X(02)00126-8 |
0.37 |
|
| 2003 |
Stastny J, Konstantinidis A, Schwarz MJ, Rosenthal NE, Vitouch O, Kasper S, Neumeister A. Effects of tryptophan depletion and catecholamine depletion on immune parameters in patients with seasonal affective disorder in remission with light therapy. Biological Psychiatry. 53: 332-7. PMID 12586452 DOI: 10.1016/S0006-3223(02)01453-1 |
0.368 |
|
| 2003 |
Hilger E, Barnas C, Kasper S. Quetiapine in the treatment of borderline personality disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 4: 42-4. PMID 12582977 DOI: 10.3109/15622970309167910 |
0.345 |
|
| 2003 |
Riederer F, Stamenkovic M, Schindler SD, Kasper S. [Tourette's syndrome - a review]. Der Nervenarzt. 73: 805-19. PMID 12215871 DOI: 10.1007/S00115-002-1270-Y |
0.312 |
|
| 2003 |
Winkler D, Pjrek E, Pezawas L, Presslich O, Tauscher J, Kasper S, Lai I, Hong C, Tsai S, Huo S, Yen F, Tung C, Pan G, Watanabe M, Harada S, et al. Contents Vol. 48, 2003 Neuropsychobiology. 48: 221-222. DOI: 10.1159/000075624 |
0.532 |
|
| 2003 |
Winkler D, Pjrek E, Pezawas L, Presslich O, Tauscher J, Kasper S, Lai I, Hong C, Tsai S, Huo S, Yen F, Tung C, Pan G, Watanabe M, Harada S, et al. Subject Index Vol. 48, 2003 Neuropsychobiology. 48: 219-220. DOI: 10.1159/000075623 |
0.541 |
|
| 2003 |
Winkler D, Pjrek E, Pezawas L, Konstantinidis A, Presslich O, Tauscher J, Kasper S. P.6.060 Influence of psychopharmacologic treatment on short-term actigraphic measurements European Neuropsychopharmacology. 13: S451. DOI: 10.1016/S0924-977X(03)92358-3 |
0.578 |
|
| 2003 |
Frey R, Gruber S, Reinfried L, Stadlbauer A, Mlnarik V, Kasper S, Moser E. P.1.240 Proton magnetic resonance spectroscopy in depression: Elevated creatine and unaffected myo-inositol levels in the frontal brain European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91950-X |
0.314 |
|
| 2003 |
Konstantinidis A, Ptak-Butta J, Stastny J, Winkler D, Pjrek E, Barnas C, Neumeister A, Kasper S. P.1.198 Follow-up of patients with major depression treated with intravenous mirtazapine European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91908-0 |
0.392 |
|
| 2003 |
Klein N, Wiesegger G, Winkler D, Attarbaschi T, Mossaheb N, Kasper S, Tauscher J. P.1.149 Escitalopram for treatment of depression and anxiety disorder in adult outpatients European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91859-1 |
0.395 |
|
| 2003 |
Volz H, Murck H, Kasper S, Möller H. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial Psychopharmacology. 167: 333-333. DOI: 10.1007/s00213-003-1420-3 |
0.397 |
|
| 2002 |
Gupta R, Kumar R, Kasper S. Physical signs in psychiatry: a step towards evidence-based medicine. International Journal of Psychiatry in Clinical Practice. 6: 69-72. PMID 24931931 DOI: 10.1080/136515002753724054 |
0.325 |
|
| 2002 |
Kasper S. Sertindole: safety and tolerability profile. International Journal of Psychiatry in Clinical Practice. 6: 27-32. PMID 24931887 DOI: 10.1080/13651500215967 |
0.301 |
|
| 2002 |
Kasper S, Olié JP. A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression European Psychiatry. 17: 331-340. PMID 15177089 DOI: 10.1016/S0924-9338(02)00651-X |
0.406 |
|
| 2002 |
Winkler D, Willeit M, Wolf R, Stamenkovic M, Tauscher J, Pjrek E, Konstantinidis A, Schindler S, Barnas C, Kasper S. Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder European Neuropsychopharmacology. 13: 129-134. PMID 12650958 DOI: 10.1016/S0924-977X(02)00174-8 |
0.41 |
|
| 2002 |
Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, et al. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 3: 133-46. PMID 12478878 DOI: 10.3109/15622970209150614 |
0.648 |
|
| 2002 |
Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, Vieta E, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders, Part I: Treatment of Bipolar Depression World Journal of Biological Psychiatry. 3: 115-124. PMID 12478876 DOI: 10.3109/15622970209150612 |
0.355 |
|
| 2002 |
Kasper S, Dienel A. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology. 164: 301-308. PMID 12424554 DOI: 10.1007/S00213-002-1203-2 |
0.363 |
|
| 2002 |
Pezawas L, Stamenkovic M, Jagsch R, Ackerl S, Putz C, Stelzer B, Moffat RR, Schindler S, Aschauer H, Kasper S. A longitudinal view of triggers and thresholds of suicidal behavior in depression. The Journal of Clinical Psychiatry. 63: 866-73. PMID 12416595 DOI: 10.4088/Jcp.V63N1003 |
0.601 |
|
| 2002 |
Schindler SD, Graf A, Fischer P, Tölk A, Kasper S. Paranoid delusions and hallucinations and bright light therapy in Alzheimer's disease. International Journal of Geriatric Psychiatry. 17: 1071-1072. PMID 12404657 DOI: 10.1002/Gps.497 |
0.316 |
|
| 2002 |
Hirschfeld RM, Montgomery SA, Aguglia E, Amore M, Delgado PL, Gastpar M, Hawley C, Kasper S, Linden M, Massana J, Mendlewicz J, Möller HJ, Nemeroff CB, Saiz J, Such P, et al. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. The Journal of Clinical Psychiatry. 63: 826-37. PMID 12363125 DOI: 10.4088/Jcp.V63N0913 |
0.354 |
|
| 2002 |
Winkler D, Praschak-Rieder N, Willeit M, Lucht MJ, Hilger E, Konstantinidis A, Stastny J, Thierry N, Pjrek E, Neumeister A, Möller HJ, Kasper S. [Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics]. Der Nervenarzt. 73: 637-43. PMID 12212526 DOI: 10.1007/s00115-002-1320-5 |
0.412 |
|
| 2002 |
Frey R, Schreinzer D, Stimpfl T, Vycudilik W, Berzlanovich A, Kasper S. [Fatal poisonings with antidepressive drugs and neuroleptics. Analysis of a correlation with prescriptions in Vienna 1991 to 1997]. Der Nervenarzt. 73: 629-36. PMID 12212525 DOI: 10.1007/S00115-001-1255-2 |
0.307 |
|
| 2002 |
Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, Paykel E, Versiani M, Racagni G. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 461-75. PMID 12208564 DOI: 10.1016/S0924-977X(02)00057-3 |
0.393 |
|
| 2002 |
Kasper S, Müller-Spahn F. Intravenous antidepressant treatment: focus on citalopram. European Archives of Psychiatry and Clinical Neuroscience. 252: 105-9. PMID 12192466 DOI: 10.1007/s00406-002-0363-8 |
0.413 |
|
| 2002 |
Winkler D, Willeit M, Praschak-Rieder N, Lucht MJ, Hilger E, Konstantinidis A, Stastny J, Thierry N, Pjrek E, Neumeister A, Möller HJ, Kasper S. Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample. European Archives of Psychiatry and Clinical Neuroscience. 252: 54-62. PMID 12111337 DOI: 10.1007/s004060200012 |
0.31 |
|
| 2002 |
Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M, Praschak-Rieder N, Zach J, De Zwaan M, Bondy B, Ackenheil M, Kasper S. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression Archives of General Psychiatry. 59: 613-620. PMID 12090814 DOI: 10.1001/Archpsyc.59.7.613 |
0.328 |
|
| 2002 |
Pezawas L, Stamenkovic M, Aschauer N, Moffat R, Kasper S. Successful treatment of recurrent brief depression with reboxetine -- a single case analysis. Pharmacopsychiatry. 35: 75-6. PMID 11951149 DOI: 10.1055/s-2002-25023 |
0.601 |
|
| 2002 |
Pezawas L, Fischer G, Podreka I, Schindler S, Brücke T, Jagsch R, Thurnher M, Kasper S. Opioid addiction changes cerebral blood flow symmetry. Neuropsychobiology. 45: 67-73. PMID 11893862 DOI: 10.1159/000048679 |
0.573 |
|
| 2002 |
Praschak-Rieder N, Willeit M, Winkler D, Neumeister A, Hilger E, Zill P, Hornik K, Stastny J, Thierry N, Ackenheil M, Bondy B, Kasper S. Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 129-34. PMID 11872329 DOI: 10.1016/s0924-977x(01)00146-8 |
0.312 |
|
| 2002 |
Kasper S, Wolf R. Successful treatment of reboxetine-induced urinary hesitancy with tamsulosin. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 119-22. PMID 11872327 DOI: 10.1016/S0924-977X(01)00144-4 |
0.345 |
|
| 2002 |
Kasper S. Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study. Psychopharmacology. 159: 445-446. PMID 11823898 DOI: 10.1007/S00213-001-0971-4 |
0.374 |
|
| 2002 |
Konstantinidis A, Stastny J, Ptak-Butta J, Hilger E, Winkler D, Barnas C, Neumeister A, Kasper S. Intravenous mirtazapine in the treatment of depressed inpatients. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 57-60. PMID 11788241 DOI: 10.1016/s0924-977x(01)00132-8 |
0.382 |
|
| 2002 |
Letmaier M, Schreinzer D, Wolf R, Kasper S. Topiramate as a mood stabilizer. International Clinical Psychopharmacology. 16: 295-8. PMID 11552774 DOI: 10.1097/00004850-200109000-00008 |
0.328 |
|
| 2002 |
Winkler D, Tauscher J, Kasper S. Maintenance treatment in depression: the role of pharmacological and psychological treatment Current Opinion in Internal Medicine. 1: 209-214. DOI: 10.1097/00132980-200201020-00017 |
0.371 |
|
| 2002 |
Winkler D, Tauscher J, Kasper S. Maintenance treatment in depression: the role of pharmacological and psychological treatment Current Opinion in Psychiatry. 15: 63-68. DOI: 10.1097/00001504-200201000-00011 |
0.367 |
|
| 2002 |
Bowden CL, Calabrese JR, Baldwin D, Behnke K, Kasper S, Sachs G, Yatham L, Ascher J, Paska W. Lamotrigine delays mood episodes in recently depressed bipolar I patients European Neuropsychopharmacology. 12: 216-217. DOI: 10.1016/S0924-977X(02)80238-3 |
0.391 |
|
| 2002 |
Quiner S, Jessner W, Rosenauer D, Zwaan MD, Ferenci P, Kasper S. Potential predictors of depression in patients with chronic hepatitis-C during long-term treatment with interferon alpha European Neuropsychopharmacology. 12: 175. DOI: 10.1016/S0924-977X(02)80130-4 |
0.303 |
|
| 2002 |
Hilger E, Praschak-Rieder N, Willeit M, Stastny J, Konstandinidis A, Neumeister A, Kasper S. Die Pharmakotherapie der saisonal abhängigen Depression Nervenarzt. 73: 22-31. DOI: 10.1007/978-3-7091-0592-4_20 |
0.306 |
|
| 2001 |
Willeit M, Praschak-Rieder N, Hilger E, Neumeister A, Kasper S. Reboxetine in a patient with seasonal bulimia resistant to SSRIs and light therapy. International Journal of Psychiatry in Clinical Practice. 5: 207-209. PMID 24926755 DOI: 10.1080/136515001317021680 |
0.304 |
|
| 2001 |
Kasper S. Depression and anxiety--separate or continuum? World Journal of Biological Psychiatry. 2: 162-163. PMID 12587144 DOI: 10.3109/15622970109026804 |
0.352 |
|
| 2001 |
Neumeister A, Konstantinidis A, Praschak-Rieder N, Willeit M, Hilger E, Stastny J, Kasper S. Monoaminergic function in the pathogenesis of seasonal affective disorder. The International Journal of Neuropsychopharmacology. 4: 409-20. PMID 11806867 DOI: 10.1017/S1461145701002644 |
0.35 |
|
| 2001 |
Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, Pirker W, Konstantinidis A, Kasper S. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychological Medicine. 31: 1467-73. PMID 11722161 DOI: 10.1017/s003329170105434z |
0.367 |
|
| 2001 |
Kasper S, Resinger E. Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors. European Neuropsychopharmacology. 11: 307-321. PMID 11532386 DOI: 10.1016/S0924-977X(01)00100-6 |
0.398 |
|
| 2001 |
Kasper S. Hypericum perforatum--a review of clinical studies. Pharmacopsychiatry. 34: 51-55. PMID 11518077 DOI: 10.1055/S-2001-15467 |
0.359 |
|
| 2001 |
Stamenkovic M, Aschauer HN, Riederer F, Schindler SD, Leisch F, Resinger E, Neumeister A, Hornik K, Kasper S. Study of family history in seasonal affective disorder. Neuropsychobiology. 44: 65-9. PMID 11490172 DOI: 10.1159/000054917 |
0.321 |
|
| 2001 |
Stamenkovic M, Blasbichier T, Riederer F, Pezawas L, Brandstätter N, Aschauer HN, Kasper S. Fluoxetine treatment in patients with recurrent brief depression. International Clinical Psychopharmacology. 16: 221-6. PMID 11459336 |
0.621 |
|
| 2001 |
Kasper S, Rosillon D, Duchesne I. Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study. International Clinical Psychopharmacology. 16: 179-187. PMID 11459331 DOI: 10.1097/00004850-200107000-00001 |
0.303 |
|
| 2001 |
Pezawas L, Stamenkovic M, Kasper S. [Recurrent brief depressive episodes. Epidemiology, clinical aspects, diagnosis and therapy]. Der Nervenarzt. 72: 169-80. PMID 11268761 DOI: 10.1007/s001150050736 |
0.651 |
|
| 2001 |
Praschak-Rieder N, Willeit M, Neumeister A, Hilger E, Stastny J, Thierry N, Lenzinger E, Kasper S. Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder. Journal of Affective Disorders. 63: 239-42. PMID 11246102 DOI: 10.1016/s0165-0327(00)00176-2 |
0.331 |
|
| 2001 |
Hilger E, Willeit M, Praschak-Rieder N, Stastny J, Neumeister A, Kasper S. Reboxetine in seasonal affective disorder: an open trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 11: 1-5. PMID 11226806 DOI: 10.1016/s0924-977x(00)00114-0 |
0.436 |
|
| 2001 |
El-Giamal N, de Zwaan M, Bailer U, Lennkh C, Schüssler P, Strnad A, Kasper S. Reboxetine in the treatment of bulimia nervosa: a report of seven cases. International Clinical Psychopharmacology. 15: 351-6. PMID 11110011 DOI: 10.1097/00004850-200015060-00006 |
0.393 |
|
| 2001 |
Kapitany T, Glauninger G, Schimka B, Baumgartner C, Kasper S. Risperidon in the treatment of psychotic disorder due to epilepsy European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80398-9 |
0.309 |
|
| 2001 |
Kasper S. Do antipsychotics provoke depression European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80006-7 |
0.366 |
|
| 2000 |
Angst J, Kasper S, Weiller E. Recurrent brief depression: A frequent syndrome in clinical practice International Journal of Psychiatry in Clinical Practice. 4: 195-199. PMID 24927453 DOI: 10.1080/13651500050518073 |
0.411 |
|
| 2000 |
Naber D, Kasper S. The importance of treatment acceptability to patients. International Journal of Psychiatry in Clinical Practice. 4: 25-34. PMID 24927307 DOI: 10.1080/13651500050518497 |
0.327 |
|
| 2000 |
Kasper S, el Giamal N, Hilger E. Reboxetine: the first selective noradrenaline re-uptake inhibitor. Expert Opinion On Pharmacotherapy. 1: 771-82. PMID 11249515 DOI: 10.1517/14656566.1.4.771 |
0.387 |
|
| 2000 |
Montgomery SA, Schatzberg AF, Guelfi JD, Kasper S, Nemeroff C, Swann A, Zajecka J. Pharmacotherapy of depression and mixed states in bipolar disorder. Journal of Affective Disorders. 59: S39-S56. PMID 11121826 DOI: 10.1016/S0165-0327(00)00178-6 |
0.399 |
|
| 2000 |
Heiden A, Schüssler P, Itzlinger U, Leisch F, Scharfetter J, Gebhardt C, Fuchs K, Willeit M, Nilsson L, Miller-Reiter E, Stompe T, Meszaros K, Sieghart W, Hornik K, Kasper S, et al. Association studies of candidate genes in bipolar disorders. Neuropsychobiology. 42: 18-21. PMID 11093065 DOI: 10.1159/000054846 |
0.328 |
|
| 2000 |
Meszaros K, Lenzinger E, Hornik K, Füreder T, Stompe T, Willinger U, Heiden A, Fathi N, Gerhard E, Fuchs K, Sieghart W, Kasper S, Aschauer HN. Association study of schizophrenia spectrum disorders and dopamine D3 receptor gene: is schizoaffective disorder special? Psychiatry Research. 96: 179-83. PMID 11063791 DOI: 10.1016/S0165-1781(00)00209-2 |
0.303 |
|
| 2000 |
Tauscher J, Tauscher-Wisniewski S, Kasper S. Treatment of patients with delirium. The American Journal of Psychiatry. 157: 1711. PMID 11007745 DOI: 10.1176/APPI.AJP.157.10.1711 |
0.304 |
|
| 2000 |
Pezawas L, Quiner S, Moertl D, Tauscher J, Barnas C, Küfferle B, Wolf R, Kasper S. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance. International Clinical Psychopharmacology. 15: 207-14. PMID 10954060 |
0.562 |
|
| 2000 |
Vesely C, Küfferle B, Brücke T, Kasper S. Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine. International Clinical Psychopharmacology. 15: 57-60. PMID 10836289 DOI: 10.1097/00004850-200015010-00010 |
0.331 |
|
| 2000 |
Stamenkovic M, Schindler SD, Aschauer HN, De Zwaan M, Willinger U, Resinger E, Kasper S. Effective open-label treatment of tourette's disorder with olanzapine. International Clinical Psychopharmacology. 15: 23-8. PMID 10836282 DOI: 10.1097/00004850-200015010-00003 |
0.355 |
|
| 2000 |
Hirschfeld RM, Montgomery SA, Keller MB, Kasper S, Schatzberg AF, Möller HJ, Healy D, Baldwin D, Humble M, Versiani M, Montenegro R, Bourgeois M. Social functioning in depression: a review. The Journal of Clinical Psychiatry. 61: 268-75. PMID 10830147 DOI: 10.4088/Jcp.V61N0405 |
0.325 |
|
| 2000 |
Frey R, Ortwein-Swoboda G, Heiden A, Kasper S, Gruber S, Mlynarik V, Moser E. 1H-MR-Spectroscopy of untreated depressive patients shows reduced N-acetyl aspartate, choline and myo-inositol levels in the frontal lobe European Neuropsychopharmacology. 10: 280. DOI: 10.1016/S0924-977X(00)80281-3 |
0.327 |
|
| 2000 |
Heiden A, Fischer P, Schein B, Frey R, Itzlinger U, Kasper S, Kettenbach K, BaSsalamah A, Gulesserian T, Trattnig S, Imhof H. MRI signal hyperintensities and chronicity of depression European Neuropsychopharmacology. 10: 279-280. DOI: 10.1016/S0924-977X(00)80280-1 |
0.308 |
|
| 2000 |
Pezawas L, Stamenkovic M, Jagsch R, Ackerl S, Putz C, Stelzer B, Aschauer H, Kasper S. Suicidal behavior in patients with recurrent brief depression (RBD) European Neuropsychopharmacology. 10: 274. DOI: 10.1016/S0924-977X(00)80268-0 |
0.61 |
|
| 2000 |
Bailer U, Aschauer HN, Kasper S. P02.364 Efficacy of antidepressants in the treatment of severe depression European Psychiatry. 15. DOI: 10.1016/S0924-9338(00)94771-0 |
0.396 |
|
| 2000 |
Heiden A, Kettenbach K, Fischer P, Schein B, Bassalamah A, Frey R, Gulesserian T, Itzlinger U, Trattnig S, Imhof H, Kasper S. P01.177 White matter lesions and chronicity of depression European Psychiatry. 15. DOI: 10.1016/S0924-9338(00)94584-X |
0.311 |
|
| 2000 |
Neumeister A, Graf A, Willeit M, Kasper S. P01.02 Light therapy for treatment indications other than seasonal affective disorder European Psychiatry. 15. DOI: 10.1016/S0924-9338(00)94413-4 |
0.318 |
|
| 2000 |
Stamenkovic M, Blasbichler T, Brandstätter N, Pezawas L, Aschauer H, Kasper S. 308. Fluoxetine treatment in patients with recurrent brief depression (RBD) Biological Psychiatry. 47: S93. DOI: 10.1016/S0006-3223(00)00572-2 |
0.639 |
|
| 1999 |
Neumeister A, Praschak-Rieder N, Willeit M, Stastny J, Kasper S. Monoamine depletion in non-pharmacological treatments for depression. Advances in Experimental Medicine and Biology. 467: 29-33. PMID 10721035 DOI: 10.1007/978-1-4615-4709-9_4 |
0.361 |
|
| 1999 |
Kasper S, Tauscher J, Küfferle B, Barnas C, Pezawas L, Quiner S. Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 249: 83-9. PMID 10654113 DOI: 10.1007/Pl00014189 |
0.604 |
|
| 1999 |
Kasper S, Pezawas L. [Depression and anxiety]. Wiener Medizinische Wochenschrift (1946). 149: 494-502. PMID 10637953 |
0.597 |
|
| 1999 |
Kapitany T, Schindl M, Schindler SD, Hesselmann B, Füreder T, Barnas C, Sieghart W, Kasper S. The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Research. 88: 75-88. PMID 10622344 DOI: 10.1016/S0165-1781(99)00082-7 |
0.385 |
|
| 1999 |
Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stühlinger G, Pezawas L, Aschauer HN, Kasper S. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction (Abingdon, England). 94: 1337-47. PMID 10615719 DOI: 10.1046/J.1360-0443.1999.94913376.X |
0.588 |
|
| 1999 |
Kasper S. From symptoms to social functioning: differential effects of antidepressant therapy. International Clinical Psychopharmacology. 14: 27-31. PMID 10468326 DOI: 10.1097/00004850-199905001-00006 |
0.304 |
|
| 1999 |
Tauscher J, Pirker W, de Zwaan M, Asenbaum S, Brücke T, Kasper S. In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: 177-9. PMID 10082245 DOI: 10.1016/S0924-977X(98)00013-3 |
0.305 |
|
| 1999 |
Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol. Psychopharmacology. 141: 175-81. PMID 9952042 DOI: 10.1007/s002130050822 |
0.594 |
|
| 1999 |
Lennkh C, Fischer P, Küfferle B, Kasper S. Occurrence of trazodone-induced delirium. International Clinical Psychopharmacology. 13: 225-8. PMID 9817628 DOI: 10.1097/00004850-199809000-00006 |
0.326 |
|
| 1999 |
Neumeister A, Habeler A, Praschak-Rieder N, Willeit M, Kasper S. Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder? International Clinical Psychopharmacology. 14: 313-316. DOI: 10.1097/00004850-199909000-00006 |
0.407 |
|
| 1999 |
Pezawas L, Stamenkovic M, Ackerl S, Putz C, Stelzer B, Blasbichler T, Schindler S, Aschauer H, Kasper S. Clinical characteristics of patients with recurrent brief depression (RBD) European Neuropsychopharmacology. 9: 245. DOI: 10.1016/S0924-977X(99)80221-1 |
0.626 |
|
| 1999 |
Praschak-Rieder N, Willeit M, Neumeister A, Pirker W, Asenbaum S, Hilger E, Stastny J, Brücke T, Kasper S. [123I]-β-CIT SPECT shows lower midbrain serotonin transporter density in drug free depressed SAD patients European Neuropsychopharmacology. 9: 245. DOI: 10.1016/S0924-977X(99)80220-X |
0.333 |
|
| 1999 |
Hilger E, Willeit M, Praschak-Rieder N, Neumeister A, Stastny J, Thierry N, Kasper S. Rapid remission of atypical depressive symptoms with the selective noradrenalin reuptake inhibitor reboxetine in SAD patients European Neuropsychopharmacology. 9: 243. DOI: 10.1016/S0924-977X(99)80214-4 |
0.356 |
|
| 1999 |
Lucht MJ, Kasper S. Gender differences in seasonal affective disorder (SAD) Archives of Womens Mental Health. 2: 83-89. DOI: 10.1007/S007370050040 |
0.324 |
|
| 1999 |
Hesselmann B, Habeler A, Praschak-Rieder N, Willeit M, Neumeister A, Kasper S. Mirtazapine in seasonal affective disorder (SAD): a preliminary report Human Psychopharmacology-Clinical and Experimental. 14: 59-62. DOI: 10.1002/(Sici)1099-1077(199901)14:1<59::Aid-Hup67>3.0.Co;2-6 |
0.437 |
|
| 1998 |
Stamenkovic M, Pezawas L, de Zwaan M, Aschauer HN, Kasper S. Mirtazapine in recurrent brief depression. International Clinical Psychopharmacology. 13: 39-40. PMID 9988366 DOI: 10.1097/00004850-199801000-00006 |
0.651 |
|
| 1998 |
Pezawas LM, Fischer G, Diamant K, Schneider C, Schindler SD, Thurnher M, Ploechl W, Eder H, Kasper S. Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements. Psychiatry Research. 83: 139-47. PMID 9849723 DOI: 10.1016/S0925-4927(98)00028-6 |
0.582 |
|
| 1998 |
Frey R, Metzler D, Fischer P, Heiden A, Scharfetter J, Moser E, Kasper S. Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla. Journal of Psychiatric Research. 32: 411-20. PMID 9844958 DOI: 10.1016/S0022-3956(98)00033-8 |
0.341 |
|
| 1998 |
Broich K, Grünwald F, Kasper S, Klemm E, Biersack H-, Möller H-. D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects Pharmacopsychiatry. 31: 159-162. PMID 9832346 DOI: 10.1055/S-2007-979321 |
0.309 |
|
| 1998 |
Bailer U, Praschak-Rieder N, Pezawas L, Kasper S. [Mirtazapine in inpatient treatment of depressed patients]. Wiener Klinische Wochenschrift. 110: 646-50. PMID 9816638 |
0.622 |
|
| 1998 |
Ruhrmann S, Kasper S, Hawellek B, Martinez B, Höflich G, Nickelsen T, Möller HJ. Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder. Psychological Medicine. 28: 923-33. PMID 9723147 DOI: 10.1017/S0033291798006813 |
0.386 |
|
| 1998 |
Hasse-Sander I, Müller H, Schurig W, Kasper S, Möller HJ. [Effects of electroconvulsive therapy on cognitive functions in therapy-refractory depression]. Der Nervenarzt. 69: 609-16. PMID 9715479 DOI: 10.1007/s001150050318 |
0.323 |
|
| 1998 |
Kasper S. How much do novel antipsychotics benefit the patients? International Clinical Psychopharmacology. S71-7. PMID 9690974 DOI: 10.1097/00004850-199803003-00012 |
0.317 |
|
| 1998 |
Kasper S, Küfferle B. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates. Journal of Clinical Psychopharmacology. 18: 353-6. PMID 9690709 DOI: 10.1097/00004714-199808000-00024 |
0.31 |
|
| Show low-probability matches. |